Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PEROVSKITE PRODUCTION PROCESS
Document Type and Number:
WIPO Patent Application WO/2023/047116
Kind Code:
A1
Abstract:
The invention relates to a process for producing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A]a[M]b[X]c, wherein: [M] comprises one or more M cations, which one or more M cations are metal or metalloid cations; [A] comprises one or more A cations, wherein the one or more A cations comprise a first cation A' and a second cation A'', wherein the second cation A'' is different from the first cation A'; [X] comprises one or more halide anions; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19; and wherein the compound comprises layers and/or chains of corner-sharing MX6 octahedra separated by the second cation A''; wherein the process comprises disposing on a substrate a precursor composition comprising: (a) a first precursor compound comprising the one or more M cations, which one or more M cations are metal or metalloid cations; (b) a second precursor compound comprising the first cation A' and (c) a solvent, wherein the solvent comprises: (i) a compound which provides the second cation A''; and (ii) an organic solvent.

Inventors:
SNAITH HENRY JAMES (GB)
GALLANT BENJAMIN MARK (GB)
HOLZHEY PHILIPPE JURGEN (GB)
Application Number:
PCT/GB2022/052403
Publication Date:
March 30, 2023
Filing Date:
September 22, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV OXFORD INNOVATION LTD (GB)
International Classes:
H01L51/42; H01L51/50
Domestic Patent References:
WO2017153752A12017-09-14
Other References:
AHMAD SAJJAD ET AL: "Dion-Jacobson Phase 2D Layered Perovskites for Solar Cells with Ultrahigh Stability", JOULE, vol. 3, no. 3, 1 March 2019 (2019-03-01), pages 794 - 806, XP055925807, ISSN: 2542-4351, DOI: 10.1016/j.joule.2018.11.026
LI PENGWEI ET AL: "Low-Dimensional Perovskites with Diammonium and Monoammonium Alternant Cations for High-Performance Photovoltaics", ADVANCED MATERIALS, vol. 31, no. 35, 3 July 2019 (2019-07-03), DE, pages 1901966, XP055925812, ISSN: 0935-9648, DOI: 10.1002/adma.201901966
CHENG FANGWEN ET AL: "Low-Temperature Fabrication of Phase-Pure [alpha]-FAPbI 3 Films by Cation Exchange from Two-Dimensional Perovskites for Solar Cell Applications", ENERGY & FUELS, vol. 35, no. 23, 17 August 2021 (2021-08-17), WASHINGTON, DC, US., pages 19035 - 19044, XP055925815, ISSN: 0887-0624, DOI: 10.1021/acs.energyfuels.1c02175
WANG JUNHUI ET AL: "Engineered Directional Charge Flow in Mixed Two-Dimensional Perovskites Enabled by Facile Cation-Exchange", THE JOURNAL OF PHYSICAL CHEMISTRY C, vol. 121, no. 39, 21 September 2017 (2017-09-21), US, pages 21281 - 21289, XP055925824, ISSN: 1932-7447, DOI: 10.1021/acs.jpcc.7b08535
YI WEI ET AL: "An overview on enhancing the stability of lead halide perovskite quantum dots and their applications in phosphor-converted LEDs", CHEMICAL SOCIETY REVIEWS, vol. 48, no. 1, 22 November 2018 (2018-11-22), UK, pages 310 - 350, XP055709448, ISSN: 0306-0012, DOI: 10.1039/C8CS00740C
DOOLIN ALEXANDER JAMES ET AL: "Sustainable solvent selection for the manufacture of methylammonium lead triiodide (MAPbI 3 ) perovskite solar cells", GREEN CHEMISTRY, vol. 23, no. 6, 1 January 2021 (2021-01-01), GB, pages 2471 - 2486, XP055925822, ISSN: 1463-9262, DOI: 10.1039/D1GC00079A
FAN YINGPING ET AL: "Review of Stability Enhancement for Formamidinium-Based Perovskites", SOLAR RRL, vol. 3, no. 9, 15 August 2019 (2019-08-15), pages 1900215, XP055925828, ISSN: 2367-198X, DOI: 10.1002/solr.201900215
TONG GUOQING ET AL: "Removal of residual compositions by powder engineering for high efficiency formamidinium-based perovskite solar cells with operation lifetime over 2000 h", NANO ENERGY, vol. 87, 1 September 2021 (2021-09-01), NL, pages 106152, XP093002144, ISSN: 2211-2855, DOI: 10.1016/j.nanoen.2021.106152
JEONG ET AL.: "Pseudo-halide anion engineering for a-FAPbI3 perovskite solar cells", NATURE, 2021
DOOLIN, A.J. ET AL.: "Sustainable solvent selection for the manufacture of methylammonium lead triiodide (MAPbI ) perovskite solar cells", GREEN CHEM., vol. 23, 2021, pages 2471 - 2486, XP055925822, DOI: 10.1039/D1GC00079A
N. K. NOEL ET AL.: "A low viscosity, low boiling point, clean solvent system for the rapid crystallisation of highly specular perovskite films", ENERGY ENVIRON. SCI., vol. 10, 2017, pages 145 - 152, XP055589901, DOI: 10.1039/C6EE02373H
ZHANG, Y. ET AL.: "From 2D to 3D: A facile and effective procedure for fabrication of planar CH3NH PbI perovskite solar cells", J. MATER. CHEM. A, vol. 6, 2018, pages 17867 - 17873, XP055645579, DOI: 10.1039/C8TA07048B
TAUC, J.GRIGOROVICI, R.VANCU: "Optical Properties and Electronic Structure of Amorphous Germanium", PHYS. STATUS SOLIDI, vol. 15, 1966, pages 627 - 637
BARKHOUSE DARGUNAWAN OGOKMEN TTODOROV TKMITZI DB: "Device characteristics of a 10.1% hydrazineprocessed Cu2ZnSn(Se,S)4 solar cell", PROGRESS IN PHOTOVOLTAICS: RESEARCH AND APPLICATIONS, 2012
KIESLICH ET AL.: "An extended Tolerance Factor approach for organic-inorganic perovskites", CHEMICAL SCIENCE, vol. 6, 2015, pages 3430 - 3433, XP055481666, DOI: 10.1039/C5SC00961H
WANG ET AL.: "Efficient ambient-air-stable solar cells with 2D-3D heterostructured butylammonium-caesium-formamidinium lead halide perovskites", NATURE ENERGY, vol. 2, no. 17135, 2017
MA ET AL.: "Temperature-Dependent Thermal Decomposition Pathway of Organic-Inorganic Halide Perovskite Materials", CHEM. MATER, vol. 31, 2019
Attorney, Agent or Firm:
J A KEMP LLP (GB)
Download PDF:
Claims:
CLAIMS 1. A process for producing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A]a[M]b[X]c, wherein: [M] comprises one or more M cations, which one or more M cations are metal or metalloid cations; [A] comprises one or more A cations, wherein the one or more A cations comprise a first cation A’ and a second cation A’’, wherein the second cation A’’ is different from the first cation A’; [X] comprises one or more halide anions; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19; and wherein the compound comprises layers and/or chains of corner-sharing MX6 octahedra separated by the second cation A’’; wherein the process comprises disposing on a substrate a precursor composition comprising: (a) a first precursor compound comprising the one or more M cations, which one or more M cations are metal or metalloid cations; (b) a second precursor compound comprising the first cation A’ and (c) a solvent, wherein the solvent comprises: (i) a compound which provides the second cation A’’; and (ii) an organic solvent. 2. The process according to claim 1, wherein the ratio R of the concentration in the precursor composition of the compound which, when protonated, provides the second cation, A’’, to the concentration in the precursor composition of the first organic cation A’, is from 0.75 to 3, preferably wherein R is from 1 to 1.75. 3. The process according to claim 1 or claim 2, wherein the organic solvent comprises an ether, preferably wherein the organic solvent comprises a cyclic ether, more preferably wherein the cyclic ether is tetrahydrofuran, 2- methyltetrahydrafuran or a mixture thereof. 4. The process according to any preceding claim, wherein first cation A’ is (i) an inorganic cation, preferably wherein the first cation A’ is selected from the group consisting of Na+, K+, Cs+, Rb, or (ii) an organic cation, preferably wherein the first cation A’ is selected from the group consisting of ammonium cations and iminium cations, more preferably wherein A’ is selected from ammonium cations, formamidinium cations and guanidinium cations, more preferably wherein the first cation A’ is methyl ammonium. 5. The process according to any one of the preceding claims wherein the second cation A’’ is an organic cation, wherein the solvent comprises an organic compound which, when protonated, provides the second organic cation A’’, preferably wherein the second cation A’’ is an ammonium cation, wherein the solvent comprises an amine which, when protonated, provides the second organic cation A’’. 6. The process according to any one of the preceding claims, wherein the second cation A’’ is selected from the group consisting of propylammonium [(CH3CH2CH2NH3)+], butylammonium [(CH3CH2CH2CH2NH3)+], pentylammonium [(CH3CH2CH2CH2CH2NH3)+], hexylammonium [(CH3CH2CH2CH2CH2CH2NH3)+], heptylammonium [(CH3CH2CH2CH2CH2CH2CH2NH3)+] and octylammonium [(CH3CH2CH2CH2CH2CH2CH2CH2NH3)+], preferably wherein the second cation A’’ is butylammonium [(CH3CH2CH2CH2NH3)+]; orwherein the second cation A’’ is a dication selected from the group consisting of propyldiammonium [(NH3CH2CH2CH2NH3)2+], butyldiammonium [(NH3CH3CH2CH2CH2NH3) 2+], pentyldiammonium [(NH3CH3CH2CH2CH2CH2NH3) 2+], hexyldiammonium [(NH3CH3CH2CH2CH2CH2CH2NH3) 2+], heptyldiammonium [(NH3CH3CH2CH2CH2CH2CH2CH2NH3) 2+] and octyldiammonium [(NH3CH3CH2CH2CH2CH2CH2CH2CH2NH3) 2+], preferably wherein the second cation A’’ is octyldiammonium [(NH3CH2CH2CH2CH2NH3) 2+]. 7. The process according to any one of the preceding claims, wherein the one or more M cations are selected from Ca2+, Sr2+, Cd2+, Cu2+, Ni2+, Mn2+, Fe2+, Co2+, Pd2+, Ge2+, Sn2+, Pb2+, Yb2+, Eu2+, Pd2+, Bi3+, Sb3+, W4+, Re4+, Os4+, Ir4+, Pt4+, Sn4+, Ag+, Bi3+, Pb4+, Ge4+ and Te4+, preferably wherein the one or more M cations are selected from Pb2+, Ge2+, Sn2+, Ag+ and Bi3+, more preferably wherein the one or more M cations comprise Pb2+.

8. The process according to any one of the preceding claims, wherein the one or more halide anions are selected from F-, Cl-, Br- and I-, optionally wherein the one or more halide anions are selected from Cl-, Br- and I-, preferably wherein the one or more halide anions comprise I- or Br-. more preferably wherein the one or more halide anions comprise I-. 9. The process according to any one of claims 1 to 8, wherein (a) the crystalline compound of formula [A]a[M]b[X]c is a Ruddlesden Popper phase, preferably wherein the crystalline compound of formula [A]a[M]b[X]c is a compound of formula (I) A’n-1A’’2[M]n[X]3n+1 wherein A’ is as defined in any one of claims 1 and 4, A’’ is as defined in any one of claims 1, 5 and 6, [M] is as defined in any one of claims 1 and 7 and [X] is as defined in any one of claims 1 and 8, and wherein n is a number from 1 to 2.5, preferably wherein n is a number from 1.3 to 2 or wherein n is a number from 1.1 to 1.9; or (b) the crystalline compound of formula [A]a[M]b[X]c is a Dion-Jacobson phase, preferably wherein the crystalline compound of formula [A]a[M]b[X]c is a is a compound of formula (II) A’n-1A’’MnX3n+1 wherein A’ is as defined in any one of claims 1 and 4, A’’ is as defined in any one of claims 1, 5 and 6, [M] is as defined in any one of claims 1 and 7 and [X] is as defined in any one of claims 1 and 8, and wherein n is from 1 to 3, preferably wherein A’’ is an organic cation with a charge of 2+ and radius larger than A’ or wherein A’’ is an organic cation with a charge of 1+ and radius larger than A’. 10. A first crystalline A/M/X material obtainable by the process as defined in any one of claims 1 to 9, optionally wherein the first crystalline A/M/X material is in the form of a layer comprising the material. 11. A first crystalline A/M/X material comprising a crystalline compound of formula (I): A’n-1A’’2[M]n[X]3n+1 wherein A’ is as defined in any one of claims 1 and 4, A’’ is as defined in any one of claims 1, 5 and 6, [M] is as defined in any one of claims 1 and 7 and [X] is as defined in any one of claims 1 and 8, and wherein n is a number from 1.1 to 1.9, optionally wherein the first crystalline A/M/X material is in the form of a layer comprising the material, preferably wherein A’ is methylammonium, A’’ is butylammonium, [M] is Pb and [X] is I. 12. A process for producing a layer comprising a second crystalline A/M/X material, which process comprises: exposing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A]a[M]b[X]c, and wherein the layer comprising the first crystalline A/M/X material is disposed on a substrate, to one or more conversion cations, Ac, wherein: [M] comprises one or more M cations, which one or more first cations are metal or metalloid cations; [A] comprises one or more A cations, wherein the one or more second cations comprise a first cation A’ and a second cation A’’, wherein the second cation A’’ is different from the first cation; [X] comprises one or more halide anions; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19 wherein the compound comprises layers and/or chains of corner-sharing MX6 octahedra separated by the second cation A’’. 13. The process according to claim 12, wherein the one or more conversion cations, Ac, replace the first cation, A’, and/or the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material, optionally wherein (a) the one or more conversion cations, Ac, replace all of the first cation, A’, and/or all of the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material; or (b) the one or more conversion cations, Ac, replace a portion of the first cation, A’, and/or a portion of the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material.

14. The process according to claims 12 or claim 13, wherein (a) the first crystalline A/M/X material is as defined in any one of claims 1 and 9; and/or (b) the first cation A’ is as defined in any one of claims 1 and 4; and/or (c) the second cation A’’ is as defined in any one of claims 1, 5 and 6; and/or (d) the one or more M cations are as defined in any one of claims 1 and 7; and/or (e) the one or more halide anions, X are as defined in any one of claims 1 and 8. 15. The process according to any one of claims 12 to 14, wherein the one or more conversion cations, Ac, are different from the first cation, A’, and the second cation, A’’, optionally wherein the one or more conversion cations, Ac, are selected from the group consisting of alkali metal cations and organic cations, preferably wherein the one or more conversion cations, Ac, are selected from the group consisting of Cs+, Rb+, K+, Na+, methylammonium [(CH3NH3)+], formamidinium [(H2N-C(H)=NH2)+], dimethylammonium [(CH3)2NH2+], methylenediammonium [(NH3CH2NH3)2+], ammonium (NH4+) and guanidinium [(H2N-C(NH2)=NH2)+], more preferably wherein the one or more conversion cations Ac, are selected from methylammonium, Cs+ and formamidinium [(H2N-C(H)=NH2)+]. more preferably still wherein the one or more conversion cations, Ac, are selected from Cs+ and formamidinium [(H2N-C(H)=NH2)+]. even more preferably wherein the conversion cation Ac, is formamidinium [(H2N-C(H)=NH2)+]. 16. The process according to any one of claims 12 to 15, wherein the structure of the second crystalline A/M/X material is different from the structure of the first crystalline A/M/X material, preferably wherein the second crystalline A/M/X material comprises a crystalline compound having a three dimensional crystal structure, more preferably wherein the second crystalline A/M/X material comprises a compound of formula (III) [A][M][X]3 wherein [A] comprises the one or more conversion cations, Ac, as defined in any one of claims 31, 36 and 37, [M] is as defined in any one of claims 1 and 15, and [X] is as defined in any one of claims 1 and 16. 17. The process according to any one of claims 1 to 9 and 12 to 16, wherein the substrate is a component for a semiconductor device.

18. The process according to any one of claims 12 to 17, wherein the process further comprises producing the layer comprising the first crystalline A/M/X material by a process as defined in any one of claims 1 to 9. 19. A layer comprising a second crystalline A/M/X material obtainable by the process of any one of claims 12 to 17. 20. A layer comprising crystalline (H2N-C(H)=NH2)PbI3 wherein the (H2N-C(H)=NH2)PbI3 exhibits an increase of less than 1.5% per hour in the ratio of the PbI2 (001) reflection to the perovskite (100) reflection when measured using X-ray diffraction analysis at a temperature of 130 ºC. 21. A layer comprising crystalline (H2N-C(H)=NH2)PbI3 wherein the (H2N-C(H)=NH2)PbI3 exhibits a residual solvent content of no more than 0.01 % by mass. 22. A process for producing a semiconductor device, which process comprises producing a layer comprising a second crystalline A/M/X material on a substrate, by a process as defined in any one of claims 12 to 18, and disposing one or more further components on the layer comprising the second crystalline A/M/X material to produce a semiconductor device. 23. A semiconductor device obtainable by the process of claim 22, optionally wherein the semiconductor device is an optoelectronic device or wherein the semiconductor device is a light emitting device. 24. A semiconductor device comprising a layer as defined in any one of claims 19 to 21, optionally wherein the semiconductor device is an optoelectronic device or wherein the semiconductor device is a light emitting device. 25. Use of a second crystalline A/M/X material as defined in any one of claims 19 to 21 as a phosphor.

Description:
PEROVSKITE PRODUCTION PROCESS FIELD OF THE INVENTION The invention relates to a process for producing a layer comprising a first crystalline A/M/X material, and a process for producing a layer comprising a second crystalline A/M/X material, using the first crystalline A/M/X material. The invention also relates to materials and devices obtainable by the processes as described herein. BACKGROUND TO THE INVENTION Lead halide perovskites APb 2+ X 3 (A = FA + /MA + /Cs + , X = Br-/I-) continue to be intensely studied as solar absorbers for photovoltaic (PV) applications due to their high absorption coefficients suitable for thin film technology, long charge-carrier diffusion lengths, and high radiative efficiencies. In single-junction devices the current certified record power conversion efficiency (PCE) stands at 25.5%. This is close to matching the very highest efficiencies delivered by silicon PV cells, and high PCEs are a way to minimise the cost of energy from PV. A key advantage of perovskite solar cells (PSCs) is that they can be processed rapidly and inexpensively via a range of low temperature deposition techniques, including solution deposition techniques, without compromising their efficacy. In order to harness the benefits of solution processing, industrially-viable (low toxicity, inexpensive, low energy-intensive) processing technologies must be developed. The tuneability of the band gap in mixed iodide–bromide lead-halide perovskites is another key advantage and has opened up the possibility of multi-junction solar cells with c-Si, currently delivering a record PCE of 29.5%, with efficiency improvements to over 32% feasible. Combining highly efficient single junction PSCs based on mid band gap (1.4–1.6 eV) materials with lower (1.0– 1.2 eV) and higher (1.8–2.0 eV) band gap materials allows the construction of triple-junction solar cells with the potential to achieve higher PCEs than for single-junction or tandem solar cells. While the bandgap tunability of hybrid perovskites has opened up the possibility of multi-junction solar cells with over 30% PCE, the achievable efficiencies are still limited by the poor electronic quality and poor phase-stability of the mixed iodide-bromide perovskites. Furthermore, the stability of triiodide perovskites (typically mid band gap) and in particular phase-unstable α-FAPbI 3 – the lead- based perovskite possessing a bandgap closest to the theoretically ideal for a single junction cell are also limiting. As such, development of approaches to improve the inherent stability of all FA-based solution-processed perovskites is of particularly great interest. To date, most reports of perovskite films manufactured via solution methods use high boiling point, polar, aprotic solvents (see, for instance, Jeong, et al, Pseudo-halide anion engineering for α-FAPbI3 perovskite solar cells, Nature 2021). While the most frequently used solvent is dimethylformamide (DMF), other solvents include dimethylsulfoxide (DMSO), γ-butyrolactone and dimethylacetamide (DMA). The choice of solvent is, in this case, limited by the lead halide salts which tend to be either sparingly, or completely insoluble in most of the solvents commonly used in the processing of organic semiconductors. One of the disadvantages of using solvents such as these is the need to heat films to fairly high temperatures (≥ 100˚C) to evaporate the solvent from the as-cast films, and induce crystallisation of the perovskite or A/M/X material film. This can be somewhat circumvented by the use of a so called anti-solvent quenching method, where a film is drenched in an anti-solvent at a specified time during spin-coating, causing the immediate crystallisation of the perovskite material. However, this can complicate the process by requiring an additional anti-solvent quenching step, which is particularly difficult to replicate at-scale during the manufacturing processes. There are several problems associated with existing solution-based methods for forming films of A/M/X materials. WO 2017/153752 A1 describes a low boiling point compound solvent system with reduced toxicity which comprises an alkylamine such as methylamine (MA) which is bubbled into a host solvent acetonitrile (ACN) to promote the dissolution of the perovskite salts. The solvents most commonly used at present (such as DMF, DMSO, γ-butyrolactone and DMA) have been chosen because they are able to dissolve the precursor compounds for A/M/X materials, and particularly the metal halide precursors. However, these solvents have high boiling points, increasing the energy requirements or complexity of solution processing. They are also capable of removing pre-existing organic layers commonly used during PSC production. These solvents are known to be toxic and/or especially effective percutaneous absorption enhancers and can be correspondingly difficult to handle and may be prohibitive for large volume manufacturing due to toxicological concerns. Finally, these solvents cause problems for atmosphere purification units, and are hence challenging to employ in manufacturing. Doolin et al (Doolin, A.J. et al., Sustainable solvent selection for the manufacture of methylammonium lead triiodide (MAPbI 3 ) perovskite solar cells, Green Chem., 23, 2471-2486, 2021) describes a solvent system utilising DMSO. However, the system used is still not completely free of these high-boiling point toxic solvents Noel et al (N. K. Noel, et al., A low viscosity, low boiling point, clean solvent system for the rapid crystallisation of highly specular perovskite films, Energy Environ. Sci., 10, 145-152, 2017) describes a method which involves bubbling methylamine gas into acetonitrile. This process is complicated due to the need to bubble gas through the solvent, which may also make it difficult to accurately control the amount of methylamine absorbed by the solvent. Furthermore, methylamine is highly volatile, and can easily evaporate out of the solution, making the solution unstable for use in an open container, and posing a further toxicological risk, due to its known toxicity to humans. Miao et al (Miao, Y., From 1D to 3D: Fabrication of CH 3 NH 3 PbI 3 Perovskite Solar Cell Thin Films from (Pyrrolidinium)PbI 3 via Organic Cation Exchange Approach, Energy Technol., 8, 2000148, 2020) relies on the synthesis of a 1-dimensional (pyrrolidinium)PbI 3 precursor in hot DMF, which comprises face sharing PbI 6 octahedra. This is then subsequently converted to MAPbI 3 using methylamine gas. Again this process does not use easy-to-handle solvents. Zhang et al (Zhang, Y. et al., From 2D to 3D: A facile and effective procedure for fabrication of planar CH 3 NH 3 PbI 3 perovskite solar cells, J. Mater. Chem. A, 6, 17867-17873, 2018) relates to a process which converts a face-sharing network of PbI 6 octahedra in (n-C 3 H 7 NH 3 ) 6 Pb 4 I 14 . There is therefore a need to develop perovskite manufacturing processes which avoids the use of toxic, difficult to handle solvents and which also provides compounds having good thermal stability. Ideally, the process should also allow for accurate measurement of the various components in the solvent system. Further, such a process should ideally not compromise device performance and also be capable of providing commercially useful large area cells. SUMMARY OF THE INVENTION The present invention provides a process for producing compounds which have useful electronic and optical properties and which do not have the disadvantages associated with the prior art compounds. In particular, the compounds produced according to the process exhibit enhanced thermal stability. Further, the process itself is suitable for use with less toxic solvents, which may be produced from biorenewable sources, such as 2-methyltetrahydroguran (MeTHF). By employing a novel low- toxicity, biorenewable solvent system based on cyclic ethers undesirable high-boiling point conventional solvents, such as N,N-dimethylformamide (DMF), can be avoided. The inventors have found that useful perovskite materials with enhanced stability may be prepared via a lower dimensionality intermediate which comprises layers and/or chains of corner-sharing MX 6 octahedra separated by cations. The inventors have found that, by optimising their phase composition, such 2D perovskites may be facilely converted to 3D perovskites. These intermediates closely mimic the eventual 3D structure and minimise lattice-rearrangement upon conversion. By comparison with conventional two-step conversion via lead halide intermediates a new and highly effective general processing approach for the sequential deposition of perovskites is proposed. In- situ X-ray diffraction (XRD) measurements show the increased thermal stability of materials produced by this process, such as α-formamidinium lead triiodide (α-FAPbI 3 ), in comparison to other common FA-rich compositions. This is despite nuclear magnetic resonance (NMR) measurements revealing the presence of FA as the only non-trace organic component (usually APbI 3 perovskites require A to be a mixture of cations, such as FA and MA or FA and Cs, in order to form a stable 3D perovskite material when FA is an A-site cation). Therefore, the present invention provides improved thermal stability of a perovskite composition known to possess ideal optoelectronic properties, but be conventionally understood to be unstable. Incorporation of these α-FAPbI 3 layers into perovskite solar cells (PSCs) show steady-state power conversion efficiencies (PCEs) of 18.8 % (1 cm 2 ) and 20.5 % (0.25 cm 2 ). The invention provides a process for producing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c , wherein: [M] comprises one or more M cations, which one or more M cations are metal or metalloid cations; [A] comprises one or more A cations, wherein the one or more A cations comprise a first cation A’ and a second cation A’’, wherein the second cation A’’ is different from the first cation A’; [X] comprises one or more halide anions; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19; and wherein the compound comprises layers and/or chains of corner-sharing MX 6 octahedra separated by the second cation A’’; wherein the process comprises disposing on a substrate a precursor composition comprising: (a) a first precursor compound comprising the one or more M cations, which one or more M cations are metal or metalloid cations; (b) a second precursor compound comprising the first cation A’ and (c) a solvent, wherein the solvent comprises: (i) a compound which provides the second cation A’’; and (ii) an organic solvent. The invention also provides a first crystalline A/M/X material obtainable by the process as described herein. The invention also provides a first crystalline A/M/X material comprising a crystalline compound of formula (I): A’ n-1 A’’ 2 [M] n [X] 3n+1 wherein the first cation A’ is as described herein, the second cation A’’ is as described herein, [M] is as described herein and [X] is as described herein, and wherein n is a number from 1.1 to 1.9. The invention also provides a process for producing a layer comprising a second crystalline A/M/X material, which process comprises: exposing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c , and wherein the layer comprising the first crystalline A/M/X material is disposed on a substrate, to one or more conversion cations, A c , wherein: [M] comprises one or more M cations, which one or more first cations are metal or metalloid cations; [A] comprises one or more A cations, wherein the one or more second cations comprise a first cation A’ and a second cation A’’, wherein the second cation A’’ is different from the first cation; [X] comprises one or more halide anions; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19 wherein the compound comprises layers and/or chains of corner-sharing MX 6 octahedra separated by the second cation A’’. The invention also provides a process comprising: • producing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c , wherein: [M] comprises one or more M cations, which one or more M cations are metal or metalloid cations, as described herein; [A] comprises one or more A cations, wherein the one or more A cations comprise a first cation A’ and a second cation A’’, as described herein, wherein the second cation A’’ is different from the first cation A’; [X] comprises one or more halide anions, as described herein; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19; and wherein the compound comprises layers and/or chains of corner-sharing MX 6 octahedra separated by the second cation A’’; wherein the process comprises disposing on a substrate a precursor composition comprising: (a) a first precursor compound comprising the one or more M cations, which one or more M cations are metal or metalloid cations; (b) a second precursor compound comprising the first cation A’; and (c) a solvent, wherein the solvent comprises: (i) a compound which provides the second cation A’’; and (ii) an organic solvent, as described herein; and: exposing the layer comprising the first crystalline A/M/X material to one or more conversion cations, A c , as described herein, to form a layer comprising a second crystalline A/M/X material. The invention also provides a layer comprising a second crystalline A/M/X material obtainable by a process as described herein. The invention also provides a layer comprising crystalline (H 2 N-C(H)=NH 2 )PbI 3 wherein the (H 2 N- C(H)=NH 2 )PbI 3 exhibits an increase of less than 1.5% per hour in the ratio of the PbI 2 (001) reflection to the perovskite (100) reflection when measured using X-ray diffraction analysis at a temperature of 130 ºC. The invention also provides a layer comprising crystalline (H 2 N-C(H)=NH 2 )PbI 3 wherein the (H 2 N- C(H)=NH 2 )PbI 3 exhibits a residual solvent content of no more than 0.01 % by mass. The invention also provides a process for producing a semiconductor device, which process comprises producing a layer comprising a second crystalline A/M/X material on a substrate, by a process as described herein, and disposing one or more further components on the layer comprising the second crystalline A/M/X material to produce a semiconductor device. The invention also provides a semiconductor device obtainable by a process as described herein. The invention also provides a semiconductor device comprising a layer as described herein. The invention also provides the use of a second crystalline A/M/X material as described herein as a phosphor. A DMF- and DMSO-free, low-toxicity and industrially-viable route for solution processing 2D perovskites (Figures 1 – 4) A 2D perovskite (Figure 2 - 3) that is highly effective as an intermediate in sequential deposition of methylammonium-free 3D perovskites (Figures 5 - 7). BRIEF DESCRIPTION OF THE FIGURES Figure 1 (a) shows a schematic showing stepwise dissolution of perovskite precursors by THF or MeTHF then liquid amine and subsequent sequential deposition of 3D perovskite via 2D perovskite template. Figure 1 (b) shows the preferential properties of THF and MeTHF as solvents in industrial processes where vapour phase exposure is unavoidable. Solvents shown in (i) green are produced industrially from biorenewable sources, (ii) yellow may be produced biorenewably but typically are not, (iii) red cannot be produced from renewable sources. Although recent work has assigned MeTHF a Permitted Daily Exposure (PDE) that classifies it as a Class 3 solvent (not harmful to human health at levels accepted in the chemical industry), as a newly developed solvent it has not yet been assigned a legal Vapour Exposure Limit (VEL). However, by relative comparison with the assigned PDE of chemically analogous to THF, a similarly favourable VEL is anticipated. Figure 2 shows (top) optical images showing range of phase-mixed 2D Ruddlesden Popper phase (RPP) perovskite layers processed from ether-amine solvent systems. (bottom) Normalised Steady State Photoluminescence (SSPL) spectra corresponding to the same series of RPP perovskites of the BA 2 MA n-1 Pb n I 3n+1 family. R BA-MA+ = [BA]/[MAI] (hereafter denoted R), where [BA] = concentration of added butylamine and [MAI] = concentration of added methylammonium. Figure 3 shows the 1D X-Ray Diffraction (XRD) patterns corresponding to phase-mixed 2D RPP (BA 2 MA n-1 PbnI 3n+1 ) layers processed from ether-amine solvent systems. R BA-MA+ = [BA]/[MAI]. Lower order reflections have been labelled with the (hkl) set of planes that gives rise to them, from a given pure n 2D RPP phase. (00l) n corresponds to a diffraction signal caused by the (00l) set of planes in the n th 2D RPP phase. Figure 4 shows the 1 H solution Nuclear Magnetic Resonance (NMR) spectra of mixed-phase BA 2 MA n-1 PbnI 3n+1 RPP layers dissolved in d 6 -DMSO. Integration of the signals corresponding to MA’s and BA’s methyl groups (δ = 2.38 (s), 0.89 (t) ppm, respectively) confirm the reduction in BA:MA ratio in the deposited thin films as R is reduced. From this analysis the true value of [BA + ]/[MA + ] in 2D RPP layers, denoted [R], can be calculated and converted to a true average n of the mixed-phase layers denoted <n> via the expression: <n> = 2[R] -1 +1. Figure 5 tracks the absorbance of optimised 2D intermediate (R BA-MA+ = 1.5) converting to 3D α- FAPbI 3 during soaking in conversion solution. Unconverted 2D intermediate shown at t = 0 s. Figure 6 tracks the photoluminescence (normalised) of optimised 2D intermediate (R BA-MA+ = 1.5) converting to 3D α-FAPbI 3 during soaking in conversion solution. Unconverted 2D intermediate shown at t = 0 s. Figure 7 shows in-situ X-Ray Diffraction (XRD) patterns tracking the subsequent ripening of solution-converted 2D intermediate (R BA-MA+ = 1.5) into 3D α-FAPbI 3 under thermal annealing at 70 °C for 10 minutes, followed by 180 °C for 45 minutes. Intensity is plotted on a log scale. Figure 8 shows scanning Electron Microscopy (SEM) images showing the microstructure of 3D α- FAPbI 3 layers when a series of 2D intermediates of varying <n> are converted sequentially. Outside the desirable <n> range, continuous layers are unachievable, while within this range a controllable amount of lead iodide excess may be purposefully introduced to the layer. R = [BA]/[MAI]. R = (a) 0.75, (b) 1.00, (c) 1.25, (d) 1.50, (e) 1.75, (f) 2.00, (g) 2.50, (h) 3.00, inset: photograph showing macroscopic cracking 3D perovskite layers converted from R = 3.00 intermediates due to extreme volume contraction. Figure 9 is a plot showing lead iodide (PbI 2 ) content as a phase fraction in comparison to 2D- templated 3D α-FAPbI 3 extracted from XRD diffraction patterns via peak integration of PbI 2 (001) and α-FAPbI 3 (100) peaks. Inset shows expanded view for low-PbI 2 region. Figure 10 is a series of schematic diagrams depicting the conversion of (a) BA 2 PbI 4 (n = 1) (b) BA 2 MAPb 2 I 7 (n = 2), and (c) BA 2 MA 3 Pb 4 I 13 (n = 4) into α-FAPbI 3 . We refer to the 3D α-FAPbI 3 films processed via the 2D template as t 2D-3D. FA highlighted in green has replaced BA in the organic channels of the 2D intermediate, while FA highlighted in yellow has replaced MA in the inorganic layers. Where the 2D RPP phase mixture features too much of the n = 1 phase (high R, low <n>) full FA intercalation is achieved, however the significant volume contraction required for n = 1 conversion to the t 2D-3D α-FAPbI 3 lattice leads to mesoscopic cracking of the 3D perovskite layer (Figure 8g-h). Conversely, complete intercalation of FA within the pre-existing inorganic lattice is challenging for low R (high <n>) phase mixtures with too much n = 4 present, leading to lead iodide defects, which ripen to form lead iodide grains upon thermal annealing (Figure 8b-f). In the extreme case, lattice contraction due to lead iodide growth leads to mesoscopic cracking (Figure 8a). Figure 11 shows 1 H solution Nuclear Magnetic Resonance (NMR) spectra of (a) 2D template (R BA- MA+ = 1.5) and (b) converted t 2D-3D α-FAPbI 3 demonstrating no sign of residual methylammonium- or butylammonium-incorporation in the 3D perovskite composition. Figure 12 (a) shows the External Quantum Efficiency (EQE), integrated short circuit current (J sc ) of high performance PSC based on t 2D-3D α-FAPbI 3 . A photovoltaic bandgap ( PV E g ) of 1.52 eV is demonstrated for the perovskite material based on a fitting of the first derivative of the EQE. Figure 12 (b) shows the Tauc Analysis to determine the optical bandgap. Figure 12 (c) shows the Urbach energy, associated with below bandgap defect states, extracted from absorption measurements of the perovskite material. Figure 13 shows (a, b, c) absorption spectra of state-of-the-art FA 0.83 Cs 0.17 Pb(I 0.9 Br 0.1 ) 3 fabricated via conventional DMF:DMSO solvent mixtures (a), α-FAPbI 3 fabricated with excess MACl via conventional DMF:DMSO solvent mixtures (b), and α-FAPbI 3 ( t 2D-3D) fabricated via our ether- amine system (c), respectively, before and after thermal treatments. (d, e, f) 1D XRD patterns of A, B and C, respectively, during thermal treatment at 130 °C. (g, h, i) 1D XRD patterns of A, B and C, respectively, during thermal treatment at 85 °C. (j) Summary of degradation at 130 °C in which the integrated area of the PbI 2 (001) reflection has been compared to the integrated area of the perovskite (100) reflection. Figure 14 shows 1D XRD patterns of (a) state-of-the-art FA 0.83 Cs 0.17 Pb(I 0.9 Br 0.1 ) 3 fabricated via conventional DMF:DMSO solvent mixtures, (b) α-FAPbI 3 fabricated via conventional DMF:DMSO solvent mixtures, and (c) t 2D-3D α-FAPbI 3 , as they are aged under ambient conditions. The black diamonds denote reflections corresponding to the fluorine-doped tin oxide substrate. Figure 15 shows thermal desorption-gas chromatography-mass spectrometry (TD-GC-MS) measurements. Chromatograms corresponding to thermal desorption from (a) FA 0.83 Cs 0.17 Pb(I 0.9 Br 0.1 ) 3 fabricated via conventional DMF:DMSO solvent mixtures, (b) α-FAPbI 3 fabricated via conventional DMF:DMSO solvent mixtures, and (c) t 2D-3D α-FAPbI 3 . (i-viii) Mass spectra of identifiable desorption products. All species are identified using the national institute of standards and technology (NIST) 17 database and show an identification score of at least ≥90 %. Figure 16 (a) shows absorbance spectra of 2D templates alloying varying mol % of bromide alongside iodide. Figure 16 (b) shows the corresponding 1D XRD spectra. Figure 17(a) shows the Tauc Analysis of 2D templates with varying bromide converted to 3D using a solution of formamidinium bromide (FABr) in n-butanol. Figure 17 (b) shows the corresponding 1D XRD spectra. Figure 18 (a) shows a Scanning Electron Microscopy (SEM) image of 3D mixed-halide perovskite formed via conversion of a 2D template with 33 mol % bromide with a conversion solution of formamidinium bromide (FABr) in n-butanol. Figure 18 (b) is a Tauc Analysis of the same material showing an optical bandgap of 1.95 eV. Figure 19 shows the J-V characteristics of champion (a) 0.25 cm 2 and (c) 1 cm 2 device. Maximum power point tracking of champion (b) 0.25 cm 2 device. and (c) 1 cm 2 device. Figure 20 shows data relative to an unsuccessful n = ∞ (MAPbI 3 ) template. Figure 20(a) shows absorption coefficient spectra corresponding to a MAPbI 3 layer (500 nm, processed via acetonitrile/methylamine gas) (middle curve) serving as the n = ∞ member of the BA 2 MA n-1 Pb n I 3n+1 family of templates and undergoing an attempted conversion to α-FAPbI 3 (right hand curve) (cured at 180 °C for 30 minutes). t 2D-3D α-FAPbI 3 is shown for comparison (left hand curve). Figure 20(b) shows cross-sectional scanning electron microscopy (SEM) images of MAPbI 3 template and (c) converted MAPbI 3 template. Figure 20(d) shows top view SEM image of converted MAPbI 3 template. Figure 21 plots tracking change in optical density (OD) of encapsulated state-of-the-art perovskite thin layers in region from 500-510 nm under 85 °C, 85 % relative humidity (a) and 85°C, 1-sun equivalent illumination (b) conditions. Data points plotted with block-colour symbols are based on smoothed absorbance spectra due to detector saturation. For this reason, OD reductions reported are for values outside the shaded region. Figure 21(c) shows visible light microscopy images of perovskite materials reported in a and b after aging treatment. Figure 22 shows J-V characteristics of further champion (a) 0.25 cm 2 and (c) 1 cm 2 device. Maximum power point tracking of champion (b) 0.25 cm 2 device, and (c) 1 cm 2 device. Figure 23(a) shows the stability of unencapsulated PSCs stored in dark in dry air, <10 % relative humidity, at room temperature. Figure 23(b) shows stability of unencapsulated PSCs at 85 °C, 85 % relative humidity (“damp heat”). Figure 23(c) shows the set-up for the experiments of 23(a) and 23(b). Figure 24 shows champion performance of 1.95 eV perovskite material (FAPbIxBr3-x), designed for use as the top cell in a silicon-perovskite-perovskite triple junction perovskite solar cell. Figure 24 (a) shows champion JV curves, Figure 24 (b) shows champion stabilised power conversion efficiency, and Figure 24 (c) shows champion stabilised Voc. DETAILED DESCRIPTION Definitions The term “crystalline” as used herein indicates a crystalline compound, which is a compound having an extended 3D crystal structure. A crystalline compound is typically in the form of crystals or, in the case of a polycrystalline compound, crystallites (i.e. a plurality of crystals having particle sizes of less than or equal to 10 μm). The crystals together often form a layer. The crystals of a crystalline material may be of any size. Where the crystals have one or more dimensions in the range of from 1 nm up to 1000 nm, they may be described as nanocrystals. The terms “organic compound” and “organic solvent” as used herein have their typical meaning in the art and would readily be understood by the skilled person. The term “crystalline A/M/X material”, as used herein, refers to a material with a crystal structure which comprises one or more A ions, one or more M ions, and one or more X ions. A ions and M ions are cations. X ions are anions. A/M/X materials typically do not comprise any further types of ions. The term “perovskite”, as used herein, refers to a material with a three-dimensional crystal structure related to that of CaTiO 3 or a material comprising a layer of material, which layer has a structure related to that of CaTiO 3 . The structure of CaTiO 3 can be represented by the formula ABX 3 , wherein A and B are cations of different sizes and X is an anion. In the unit cell, the A cations are at (0,0,0), the B cations are at (1/2, 1/2, 1/2) and the X anions are at (1/2, 1/2, 0). The A cation is usually larger than the B cation. The skilled person will appreciate that when A, B and X are varied, the different ion sizes may cause the structure of the perovskite material to distort away from the structure adopted by CaTiO 3 to a lower-symmetry distorted structure. The symmetry will also be lower if the material comprises a layer that has a structure related to that of CaTiO 3 . Materials comprising a layer of perovskite material are well known. For instance, the structure of materials adopting the K 2 NiF 4 -type structure comprises a layer of perovskite material. The skilled person will appreciate that a perovskite material can be represented by the formula [A][B][X] 3 , wherein [A] is at least one cation, [B] is at least one cation and [X] is at least one anion. When the perovskite comprises more than one A cation, the different A cations may be distributed over the A sites in an ordered or disordered way. When the perovskite comprises more than one B cation, the different B cations may be distributed over the B sites in an ordered or disordered way. When the perovskite comprises more than one X anion, the different X anions may be distributed over the X sites in an ordered or disordered way. The symmetry of a perovskite comprising more than one A cation, more than one B cation or more than one X cation, will be lower than that of CaTiO 3 . For layered perovskites the stoichiometry can change between the A, B and X ions. As an example, the [A] 2 [B][X] 4 structure can be adopted if the A cation has a too large an ionic radius to fit within the 3D perovskite structure. The term “perovskite” also includes A/M/X materials adopting a Ruddlesden-Popper phase. Ruddlesden-Popper phase refers to a perovskite with a mixture of layered and 3D components. Such perovskites can adopt the crystal structure, A n-1 A’ 2 M n X 3n+1 , where A and A’ are different cations and n is an integer, typically ranging from 1 to 8, or from 2 to 6. The term “mixed 2D and 3D” perovskite is used to refer to a perovskite film within which there exists both regions, or domains, of AMX 3 and A n-1 A’ 2 M n X 3n+1 perovskite phases. It is common to denote such a mixture by means of an average <n> value, where n need not be an integer. The term “perovskite” also includes A/M/X materials adopting a Dion-Jacobson phase. Dion- Jacobson phase refers to a perovskite with a mixture of layered and 3D components. Such perovskites can adopt the crystal structure, A q-1 A’B q X 3q+1 , where A and A’ are different cations and q is an integer, typically ranging from 1 to 8, or from 2 to 6. The term “mixed 2D and 3D” perovskite is used to refer to a perovskite film within which there exists both regions, or domains, of AMX 3 and A n-1 A’ 2 M n X 3n+1 perovskite phases. It is common to denote such a mixture by means of an average <n> value, where n need not be an integer. The term “monocation”, as used herein, refers to any cation with a single positive charge, i.e. a cation of formula A + where A is any moiety, for instance a metal atom or an organic moiety. The term “dication”, as used herein, refers to any cation with a double positive charge, i.e. a cation of formula A 2+ where A is any moiety, for instance a metal atom or an organic moiety. The term “trication”, as used herein, refers to any cation with a triple positive charge, i.e. a cation of formula A 3+ where A is any moiety, for instance a metal atom or an organic moiety. The term “tetracation”, as used herein, refers to any cation with a quadruple positive charge, i.e. a cation of formula A 4+ where A is any moiety, for instance a metal atom. The term “alkyl”, as used herein, refers to a linear or branched chain saturated hydrocarbon radical. An alkyl group may be a C 1-20 alkyl group, a C 1-14 alkyl group, a C 1-10 alkyl group, a C 1-6 alkyl group or a C 1-4 alkyl group. Examples of a C 1-10 alkyl group are methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl or decyl. Examples of C 1-6 alkyl groups are methyl, ethyl, propyl, butyl, pentyl or hexyl. Examples of C 1-4 alkyl groups are methyl, ethyl, i-propyl, n-propyl, t-butyl, s-butyl or n- butyl. If the term “alkyl” is used without a prefix specifying the number of carbons anywhere herein, it has from 1 to 6 carbons (and this also applies to any other organic group referred to herein). The term “cycloalkyl”, as used herein, refers to a saturated or partially unsaturated cyclic hydrocarbon radical. A cycloalkyl group may be a C 3-10 cycloalkyl group, a C 3-8 cycloalkyl group or a C 3-6 cycloalkyl group. Examples of a C 3-8 cycloalkyl group include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclohexenyl, cyclohex-1,3-dienyl, cycloheptyl and cyclooctyl. Examples of a C 3-6 cycloalkyl group include cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The term “alkenyl”, as used herein, refers to a linear or branched chain hydrocarbon radical comprising one or more double bonds. An alkenyl group may be a C 2-20 alkenyl group, a C 2-14 alkenyl group, a C 2-10 alkenyl group, a C 2-6 alkenyl group or a C 2-4 alkenyl group. Examples of a C 2-10 alkenyl group are ethenyl (vinyl), propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl or decenyl. Examples of C 2-6 alkenyl groups are ethenyl, propenyl, butenyl, pentenyl or hexenyl. Examples of C 2-4 alkenyl groups are ethenyl, i-propenyl, n-propenyl, s-butenyl or n-butenyl. Alkenyl groups typically comprise one or two double bonds. The term “alkynyl”, as used herein, refers to a linear or branched chain hydrocarbon radical comprising one or more triple bonds. An alkynyl group may be a C2-20 alkynyl group, a C2-14 alkynyl group, a C 2-10 alkynyl group, a C 2-6 alkynyl group or a C 2-4 alkynyl group. Examples of a C 2-10 alkynyl group are ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl, octynyl, nonynyl or decynyl. Examples of C1-6 alkynyl groups are ethynyl, propynyl, butynyl, pentynyl or hexynyl. Alkynyl groups typically comprise one or two triple bonds. The term “aryl”, as used herein, refers to a monocyclic, bicyclic or polycyclic aromatic ring which contains from 6 to 14 carbon atoms, typically from 6 to 10 carbon atoms, in the ring portion. Examples include phenyl, naphthyl, indenyl, indanyl, anthrecenyl and pyrenyl groups. The term “aryl group”, as used herein, includes heteroaryl groups. The term “heteroaryl”, as used herein, refers to monocyclic or bicyclic heteroaromatic ring which typically contains from six to ten atoms in the ring portion including one or more heteroatoms. A heteroaryl group is generally a 5- or 6-membered ring, containing at least one heteroatom selected from O, S, N, P, Se and Si. It may contain, for example, one, two or three heteroatoms. Examples of heteroaryl groups include pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, furanyl, thienyl, pyrazolidinyl, pyrrolyl, oxazolyl, oxadiazolyl, isoxazolyl, thiadiazolyl, thiazolyl, isothiazolyl, imidazolyl, pyrazolyl, quinolyl and isoquinolyl. The term “substituted”, as used herein in the context of substituted organic groups, refers to an organic group which bears one or more substituents selected from C 1-10 alkyl, aryl (as defined herein), cyano, amino, nitro, C 1-10 alkylamino, di(C 1-10 )alkylamino, arylamino, diarylamino, aryl(C 1- 10 )alkylamino, amido, acylamido, hydroxy, oxo, halo, carboxy, ester, acyl, acyloxy, C 1-10 alkoxy, aryloxy, halo(C 1-10 )alkyl, sulfonic acid, thiol, C 1-10 alkylthio, arylthio, sulfonyl, phosphoric acid, phosphate ester, phosphonic acid and phosphonate ester. Examples of substituted alkyl groups include haloalkyl, perhaloalkyl, hydroxyalkyl, aminoalkyl, alkoxyalkyl and alkaryl groups. When a group is substituted, it may bear 1, 2 or 3 substituents. For instance, a substituted group may have 1 or 2 substitutents. The term “halide” as used herein indicates the singly charged anion of an element in group VIII of the periodic table. “Halide” includes fluoride, chloride, bromide and iodide. The term “halo” as used herein indicates a halogen atom. Exemplary halo species include fluoro, chloro, bromo and iodo species. As used herein, an amino group is a radical of formula –NR 2 , wherein each R is a substituent. R is usually selected from hydrogen, alkyl, alkenyl, cycloalkyl, or aryl, wherein each of alkyl, alkenyl, cycloalkyl and aryl are as defined herein. Typically, each R is selected from hydrogen, C 1-10 alkyl, C2-10 alkenyl, and C3-10 cycloalkyl. Preferably, each R is selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, and C 3-6 cycloalkyl. More preferably, each R is selected from hydrogen and C 1-6 alkyl. A typical amino group is an alkylamino group, which is a radical of formula –NR 2 wherein at least one R is an alkyl group as defined herein. A C 1-6 alkylamino group is an alkylamino group wherein at least one R is an C 1-6 alkyl group. As used herein, an imino group is a radical of formula R 2 C=N- or –C(R)=NR, wherein each R is a substituent. That is, an imino group is a radical comprising a C=N moiety, having the radical moiety either at the N atom or attached to the C atom of said C=N bond. R is as defined herein: that is, R is usually selected from hydrogen, alkyl, alkenyl, cycloalkyl, or aryl, wherein each of alkyl, alkenyl, cycloalkyl and aryl are as defined herein. Typically, each R is selected from hydrogen, C 1-10 alkyl, C 2-10 alkenyl, and C 3-10 cycloalkyl. Preferably, each R is selected from hydrogen, C 1-6 alkyl, C 2-6 alkenyl, and C 3-6 cycloalkyl. More preferably, each R is selected from hydrogen and C 1-6 alkyl. A typical imino group is an alkylimino group, which is a radical of formula R 2 C=N- or –C(R)=NR wherein at least one R is an alkyl group as defined herein. A C 1-6 alkylimino group is an alkylimino group wherein the R substituents comprise from 1 to 6 carbon atoms. The term “ester” as used herein indicates an organic compound of the formula alkyl-C(=O)-O-alkyl, wherein the alkyl radicals are the same or different and are as defined herein. The alkyl radicals may be optionally substituted. The term “ether” as used herein indicates an oxygen atom substituted with two alkyl radicals as defined herein. The alkyl radicals may be optionally substituted, and may be the same or different. The term “ether” also embraces cyclic ethers in which the two alkyl radicals are linked so as to form a ring. As used herein, the term “ammonium” indicates an organic cation comprising a quaternary nitrogen. An ammonium cation is a cation of formula R 1 R 2 R 3 R 4 N + . R 1 , R 2 , R 3 , and R 4 are substituents. Each of R 1 , R 2 , R 3 , and R 4 are typically independently selected from hydrogen, or from optionally substituted alkyl, alkenyl, aryl, cycloalkyl, cycloalkenyl and amino; the optional substituent is preferably an amino or imino substituent. Usually, each of R 1 , R 2 , R 3 , and R 4 are independently selected from hydrogen, and optionally substituted C 1-10 alkyl, C 2-10 alkenyl, C 3-10 cycloalkyl, C 3-10 cycloalkenyl, C 6-12 aryl and C 1-6 amino; where present, the optional substituent is preferably an amino group; particularly preferably C 1-6 amino. Preferably, each of R 1 , R 2 , R 3 , and R 4 are independently selected from hydrogen, and unsubstituted C 1-10 alkyl, C 2-10 alkenyl, C 3-10 cycloalkyl, C 3-10 cycloalkenyl, C 6-12 aryl and C 1-6 amino. In a particularly preferred embodiment, R 1 , R 2 , R 3 , and R 4 are independently selected from hydrogen, C 1-10 alkyl, and C 2-10 alkenyl and C 1-6 amino. Further preferably, R 1 , R 2 , R 3 , and R 4 are independently selected from hydrogen, C 1-6 alkyl, C 2-6 alkenyl and C 1-6 amino. As used herein, the term “iminium” indicates an organic cation of formula ([R 5 R 6 N=CH-NR 7 R 8 ] + , wherein each of R 5 , R 6 , R 7 and R 8 are typically independently selected from hydrogen, or from optionally substituted alkyl, alkenyl, aryl, cycloalkyl, cycloalkenyl and amino; the optional substituent is preferably an amino or imino substituent. Thus, in a particularly preferred embodiment, of the iminium cation, R 5 , R 6 , R 7 and R 8 are independently selected from hydrogen, C 1- 10 alkyl, C 2-10 alkenyl and C 1-6 amino. In a further preferable embodiment of the iminium cation, R 5 , R 6 , R 7 and R 8 are independently selected from hydrogen, C 1-6 alkyl, C 2-6 alkenyl and C 1-6 amino. Often, the iminium cation is formamidinium, i.e. R 5 is NH 2 and R 6 , R 7 and R 8 are all H or guanidinium, i.e. R 5 and R 6 are NH 2 and R 7 and R 8 are H. The term “multi-junction device”, as used herein, refers to a single device comprising two or more optoelectronic devices, connected electronically in series with each other and positioned sequentially on top of each other. The optoelectronic device could comprise a perovskite absorber layer sandwiched between a hole and electron accepting layer. A charge recombination layer which may be a tunnel junction, separates each optoelectronic device within the multi-junction device, which are stacked on top of each other in the multi-junction device. It is typically that the band gaps of the optoelectronic semiconductors in the multi-junction device will be different from one another. Examples of multi-junction devices include a photovoltaic device, a solar cell, a photovoltaic diode, a photo detector, a photodiode, a photosensor, a chromogenic device, a light emitting transistor, a light-sensitive transistor, a phototransistor, a solid state triode, a light-emitting device, a laser or a light-emitting diode. The terms “solar cell” and “photovoltaic diode” are used interchangeably herein. The term “optoelectronic device”, as used herein, refers to devices which source, control or detect light. Light is understood to include any electromagnetic radiation. Examples of optoelectronic devices include photovoltaic devices, photodiodes (including solar cells), phototransistors, photomultipliers, photoresistors, and light emitting diodes. The term “consisting essentially of” refers to a composition comprising the components of which it consists essentially as well as other components, provided that the other components do not materially affect the essential characteristics of the composition. Typically, a composition consisting essentially of certain components will comprise greater than or equal to 95 wt% of those components or greater than or equal to 99 wt% of those components. The terms “disposing on” or “disposed on”, as used herein, refers to the making available or placing of one component on another component. The first component may be made available or placed directly on the second component, or there may be a third component which intervenes between the first and second component. For instance, if a first layer is disposed on a second layer, this includes the case where there is an intervening third layer between the first and second layers. Typically, “disposing on” refers to the direct placement of one component on another. The term “layer”, as used herein, refers to any structure which is substantially laminar in form (for instance extending substantially in two perpendicular directions, but limited in its extension in the third perpendicular direction). A layer may have a thickness which varies over the extent of the layer. Typically, a layer has approximately constant thickness. The “thickness” of a layer, as used herein, refers to the average thickness of a layer. The thickness of layers may easily be measured, for instance by using microscopy, such as electron microscopy of a cross section of a film, or by surface profilometry for instance using a stylus profilometer. The term “band gap”, as used herein, refers to the energy difference between the top of the valence band and the bottom of the conduction band in a material. The skilled person of course is readily able to measure the band gap of a semiconductor (including that of a perovskite) by using well- known procedures which do not require undue experimentation. For instance, the band gap of a semiconductor can be estimated by constructing a photovoltaic diode or solar cell from the semiconductor and determining the photovoltaic action spectrum. Alternatively the band gap can be estimated by measuring the light absorption spectra either via transmission spectrophotometry or by photo thermal deflection spectroscopy. The band gap can be determined by making a Tauc plot, as described in Tauc, J., Grigorovici, R. & Vancu, a. Optical Properties and Electronic Structure of Amorphous Germanium. Phys. Status Solidi 15, 627–637 (1966) where the square of the product of absorption coefficient times photon energy is plotted on the Y-axis against photon energy on the x- axis with the straight line intercept of the absorption edge with the x-axis giving the optical band gap of the semiconductor. Alternatively, the optical band gap may be estimated by taking the onset of the incident photon-to-electron conversion efficiency, as described in [Barkhouse DAR, Gunawan O, Gokmen T, Todorov TK, Mitzi DB. Device characteristics of a 10.1% hydrazineprocessed Cu2ZnSn(Se,S)4 solar cell. Progress in Photovoltaics: Research and Applications 2012; published online DOI: 10.1002/pip.1160.]. The term “semiconductor” or “semiconducting material”, as used herein, refers to a material with electrical conductivity intermediate in magnitude between that of a conductor and a dielectric. A semiconductor may be an negative (n)-type semiconductor, a positive (p)-type semiconductor or an intrinsic (i) semiconductor. A semiconductor may have a band gap of from 0.5 to 3.5 eV, for instance from 0.5 to 2.5 eV or from 1.0 to 2.0 eV (when measured at 300 K). The term “n-type region”, as used herein, refers to a region of one or more electron-transporting (i.e. n-type) materials. Similarly, the terms “n-type layer” refers to a layer of an electron-transporting (i.e. an n-type) material. An electron-transporting (i.e. an n-type) material could be a single electron- transporting compound or elemental material, or a mixture of two or more electron-transporting compounds or elemental materials. An electron-transporting compound or elemental material may be undoped or doped with one or more dopant elements. The term “p-type region”, as used herein, refers to a region of one or more hole-transporting (i.e. p- type) materials. Similarly, the term “p-type layer” refers to a layer of a hole-transporting (i.e. a p- type) material. A hole-transporting (i.e. a p-type) material could be a single hole-transporting compound or elemental material, or a mixture of two or more hole-transporting compounds or elemental materials. A hole-transporting compound or elemental material may be undoped or doped with one or more dopant elements. The term “electrode material”, as used herein, refers to any material suitable for use in an electrode. An electrode material will have a high electrical conductivity. The term “electrode” as used herein indicates a region or layer consisting of, or consisting essentially of, an electrode material. Process for producing layer of 2D template material The invention provides a process for producing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c , wherein: [M] comprises one or more M cations, which one or more M cations are metal or metalloid cations; [A] comprises one or more A cations, wherein the one or more A cations comprise a first cation A’ and a second cation A’’, wherein the second cation A’’ is different from the first cation A’; [X] comprises one or more halide anions; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19; and wherein the compound comprises layers and/or chains of corner-sharing MX 6 octahedra separated by the second cation A’’; wherein the process comprises disposing on a substrate a precursor composition comprising: (a) a first precursor compound comprising the one or more M cations, which one or more M cations are metal or metalloid cations; (b) a second precursor compound comprising the first cation A’ and (c) a solvent, wherein the solvent comprises: (i) a compound which provides the second cation A’’; and (ii) an organic solvent. Typically, the ratio R of the concentration in the precursor composition of the compound which, when protonated, provides the second cation, A’’, to the concentration in the precursor composition of the first cation A’, is from 0.75 to 3. R is defined as the ratio [A’’]:[A’] in the precursor composition i.e. R =[A’’]:[A’]. Preferably R is from is from 1 to 1.75.

Solvent Typically, the organic solvent does not comprise dimethylformamide (DMF). Preferably, the aprotic solvent does not comprise dimethylformamide, dimethylsulfoxide (DMSO) or mixtures thereof. Typically, the organic solvent is an aprotic solvent. The organic solvent may comprise an ether. Preferably the organic solvent comprises a cyclic ether. For instance the organic solvent may comprise tetrahydrofuran, 2-methyltetrahydrafuran or a mixture thereof. Typically, the organic solvent consists essentially of or consist of an ether, preferably a cyclic ether. For instance, the organic solvent may consist essentially of or consist of tetrahydrofuran, 2-methyltetrahydrafuran or a mixture thereof. First A cation, A’ Typically the first cation A’ is a monocation. In some instances, the first cation A’ is an inorganic cation. For instance, the first cation A’ may be an inorganic cation selected from metal cations, such alkali metal cations or alkaline earth metal cations. The first cation A’ may be selected from the group consisting of Na + , K + , Cs + , Rb + , preferably from Cs + and Rb + , preferably Cs + . In some instances the first cation A’ is an organic cation, for instance an organic monocation. Typically, the first cation A’ is selected from the group consisting of ammonium cations and immininum cations. The ammonium cation may be as described herein. Ammonium cations typically have the general formula [R 1 R 2 R 3 R 4 N] + , wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen, unsubstituted or substituted C 1-20 alkyl, and unsubstituted or substituted C 6-12 aryl. The first cation A’ may be an ammonium cation of formula [R 1 R 2 R 3 R 4 N] + , wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen and unsubstituted or substituted C 1 - 10 alkyl, preferably wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen and unsubstituted or substituted C 1-6 alkyl. Preferably at least one of R 1 , R 2 , R 3 and R 4 is not hydrogen. For instance, the first cation, A’ may be selected from ammonium, methyl ammonium, ethyl ammonium, propyl ammonium, butyl ammonium, pentyl ammonium or hexyl ammonium. Typically, the first cation A’ is methyl ammonium. The iminium cation may be as described herein. Iminium cations typically have the general formula [R 5 R 6 N=CH-NR 7 R 8 ] + , wherein each of R 5 , R 6 , R 7 and R 8 is independently selected from hydrogen, unsubstituted or substituted C 1 - 20 alkyl, and unsubstituted or substituted C 6-12 aryl. The first cation A’ may be an iminium cation of general formula [R 5 R 6 N=CH-NR 7 R 8 ] + , wherein each of R 5 , R 6 , R 7 and R 8 is independently selected from hydrogen and unsubstituted or substituted C 1 - 10 alkyl, preferably wherein each of R 5 , R 6 , R 7 and R 8 is independently selected from hydrogen and unsubstituted or substituted C 1 - 6 alkyl. Preferably, the first cation A’ is an iminium cation selected from formamidinium cations and guanidinium cations. Preferably the first cation A’ is a formamidinium cation. Thus, the first cation may be selected from the group consisting of Cs + , methylammonium and formamidinium. The second precursor compound comprising the first cation A’ is typically a salt of the first cation A’. Typically, the second precursor compound comprises the first cation A’ and one or more counter- anions. Many such counter-anions are known to the skilled person. The counter-anion may be a halide anion, a thiocyanate anion (SCN ), a tetrafluoroborate anion (BF 4 -) or an organic anion. Preferably, the counter-anion as described herein is a halide anion or an organic anion. The second precursor compound may comprise two or more counter-anions, e.g. two or more halide anions. The counter-anion may be an anion of formula RCOO , ROCOO , RSO 3 , ROP(O)(OH)O or RO , wherein R is H, substituted or unsubstituted C 1-10 alkyl, substituted or unsubstituted C2-10 alkenyl, substituted or unsubstituted C 2-10 alkynyl, substituted or unsubstituted C 3-10 cycloalkyl, substituted or unsubstituted C 3-10 heterocyclyl or substituted or unsubstituted aryl. For instance R may be H, substituted or unsubstituted C 1-10 alkyl, substituted or unsubstituted C 3-10 cycloalkyl or substituted or unsubstituted aryl. Typically R is H substituted or unsubstituted C 1-6 alkyl or substituted or unsubstituted aryl. For instance, R may be H, unsubstituted C 1-6 alkyl or unsubstituted aryl. Thus, R may be selected from H, methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopentyl, cyclohexyl and phenyl. Often, (one or more) counter-anions are selected from halide anions (e.g. F , Cl , Br and I ) and anions of formula RCOO , wherein R is H or methyl. Typically, the counter-anion is F , Cl , Br , I-, formate or acetate. Preferably, the counter-anion is Cl , Br , I or F . More preferably, the counter- anion is Cl , Br or I . Typically, the second precursor compound is a compound of formula A’Y, A’Y2, A’Y3, or A’Y4, wherein A’ is a first cation as described herein, and Y is said counter-anion. Thus, the second precursor compound may be a compound of formula A’Y, wherein A’ is the first cation as described herein, preferably wherein A’ is an first cation as described herein, and Y is F , Cl , Br , I , formate or acetate. Preferably A’ is an ammonium cation as described herein and Y is Cl , Br , I , formate or acetate, preferably Cl , Br or I . Typically, the second precursor compound is soluble in the solvent. Thus, the second precursor compound may be present in the precursor composition dissolved in the solvent. Thus the process may comprise dissolving the second precursor compound, as described herein, in the solvent to form the precursor composition. Second A cation, A’’ Typically, the second cation A’’ is a monocation or a dication. In some instances, the second cation A’’ may be an inorganic cation. For instance, the second cation A’’ may be an inorganic cation selected from metal cations, such as alkali metal cations or alkaline earth metal cations. The second cation A’’ may be a cation selected from the group consisting of Na + , K + , Cs + , Rb + , preferably from Cs + and Rb + . Typically, the second cation A’’ is an organic cation. For instance, the second cation may be an ammonium cation as described herein. Typically, the second cation is an ammonium cation having the general formula [R 1 R 2 R 3 R 4 N] + , wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen, unsubstituted or substituted C 1-20 alkyl, and unsubstituted or substituted C 6-12 aryl. Typically, the second cation A’’ is an ammonium cation of formula [R 1 R 2 R 3 R 4 N] + , wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen and unsubstituted or substituted C 1 - 10 alkyl, preferably wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen and unsubstituted or substituted C 1-6 alkyl. Preferably at least one of R 1 , R 2 , R 3 and R 4 is not hydrogen. Preferably, the second cation A’’ is selected from the group consisting of propylammonium [(CH 3 CH 2 CH 2 NH 3 ) + ], butylammonium [(CH 3 CH 2 CH 2 CH 2 NH 3 ) + ], pentylammonium [(CH 3 CH 2 CH 2 CH 2 CH 2 NH 3 ) + ], hexylammonium [(CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) + ], heptylammonium [(CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) + ] and octylammonium [(CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) + ]. More preferably the second cation A’’ is butylammonium [(CH 3 CH 2 CH 2 CH 2 NH 3 ) + ]. The second cation A’’ may be a dialkyl ammonium cation, i.e. a cation of general formula [R 1 R 2 R 3 R 4 N] + , wherein two of R 1 to R 4 are alkyl and the other two are hydrogen. For instance, the second cation A’’ may be a cation of general formula [R 1 R 2 R 3 R 4 N] + , wherein R 1 and R 2 are each independently selected from unsubstituted or substituted C 1-20 alkyl, preferably wherein R 1 and R 2 are each independently selected from unsubstituted or substituted C 1 - 10 alkyl, and wherein R 3 and R 4 are hydrogen. For instance, the second cation A’’ may be dimethylammonium [(CH 3 ) 2 NH 2 + ]. The second cation A’’ may be an organic dication. For instance, the second cation may be a diammonium cation. Typically, diammonium cations are of formula [H 3 N(CH 2 ) n NH 3 ] 2+ , in which n is from 1 to 20, preferably in which n is from 1 to 10, for example where n is from 1 to 6. The second cation A’’ may be selected from the group consisting of propylenediammonium [(NH 3 CH 2 CH 2 CH 2 NH 3 ) 2+ ], butylenediammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 NH 3 ) 2+ ], pentylenediammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ], hexylenediammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ], heptylenediammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ] and octylenediammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ]. Preferably the second cation A’’ is octylenediammonium [(NH 3 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ]. The second A cation, A’’ may be dication which is an (alkylammonium)pyridinium, typically an m- (alkylammonium)pyridinium where m is from 2 to 4 and the alkyl group is a C 1-20 alkyl group. Typically, the second cation A’’ is an organic cation, and the solvent comprises an organic compound which, when protonated, provides the second organic cation A’’. Thus, the solvent may comprise: (i) an organic compound which, when protonated, provides the second cation A’’; and (ii) an organic solvent, as described herein. Typically, the organic solvent is an aprotic solvent. The organic solvent may comprise an ether. Preferably the organic solvent comprises a cyclic ether. For instance the organic solvent may comprise tetrahydrofuran, 2-methyltetrahydrafuran or a mixture thereof. Typically, the organic solvent consists essentially of or consist of an ether, preferably a cyclic ether. For instance, the organic solvent may consist essentially of or consist of tetrahydrofuran, 2-methyltetrahydrafuran or a mixture thereof. Thus, the solvent may comprise (i) an organic compound which, when protonated, provides the second cation A’’; and (ii) an organic solvent comprising tetrahydrofuran, 2-methyltetrahydrafuran or a mixture thereof. For instance, the second cation A’’ may be an ammonium cation, and the solvent may comprise an amine which, when protonated, provides the second organic cation A’’. For example, the second cation A’’ may be an ammonium cation, and the solvent may comprise an amine which, when protonated, provides the second organic cation A’’. Thus, the second cation A’’ may be an ammonium cation as described herein and the solvent may comprise the equivalent amine. For instance, the second cation A’’ may be methylammonium and the solvent may comprise methylamine, or the second cation may be ethylammonium and the solvent may comprise ethylamine, or the second cation may be propylammonium and the solvent may comprise propylamine, or the second cation may be butylammonium and the solvent may comprise butylamine, or the second cation may be pentylammonium and the solvent may comprise pentylamine, or the second cation may be hexylammonium and the solvent may comprise hexylamine. Similarly, when the second cation A’’ is a diammonium cation, the solvent may comprise the equivalent diamine. When the second cation A’’ is a dialkylammonium cation, the solvent may comprise the equivalent dialkylamine. The compound which provides the second cation A’’ may be a salt, which may be dissolved in the organic solvent as described herein. For instance, the salt may be a salt of any second cation A’’ as described herein, with a counter anion. Typically, the counter ion is a halide anion. Third A cation, A’’’ In some instances, [A] may comprise three or more A cations, In this case, the [A] may comprise a third A cation, A’’’, which is different from the first A cation, A’, and the second A cation, A’’. The third A cation, A’’’, may be any A cation as described herein. For instance, the third A cation, A’’’ may be an inorganic cation as described herein or an organic cation as described herein. When the third A cation, A’’’, is an organic cation, the third A cation, A’’’, may be selected from the group consisting of ammonium cations, diammonium cations, dialkylammonium cations and imidinium cations. In the compounds of formula [A] a [M] b [X] c described herein, the third A cation, A’’’, may occupy the same sites as the second A cation, A’’. Such compounds may be described as “alternating cation perovskites”. For instance, the compounds of formula [A] a [M] b [X] c may comprise a first A cation, A’, as described herein, a second A cation, A’’, as described herein and a third A cation, A’’’, as described herein. The second A cation, A’’, is typically butylammonium whilst the third A cation, A’’’, may be an inorganic cation as described herein or an organic cation as described herein, such as an ammonium cation, a diammonium cation, a dialkylammonium cation or an imidinium cation as described herein. For instance, the second A cation, A’’ may be butyl ammonium and the third A cation, A’’’, may be Cs + or octylammonium. A cations The second cation A’’ may have a larger radius than the first cation A’. Ionic radii for molecular cations may be calculated as the average of the dimensions of the ion in the x, y and z directions. Further information on ionic radii may be found in Kieslich et al “An extended Tolerance Factor approach for organic-inorganic perovskites”, Chemical Science, 6, 2015, 3430-3433. Typically, the first cation A’ has a different molecular weight from the second cation A’’. For instance, the first cation A’ may have a lower molecular weight than the second cation A’’. The first cation A’ may be an inorganic cation as described herein whilst the second cation A’’ may be an organic cation as described herein. The first cation A’ may be an organic cation as described herein whilst the second cation A’’ may be an inorganic cation as described herein. Alternatively, both the first and second cations may be inorganic cations. Preferably, both the first and second cations are organic cations, as described herein. Typically, the first cation is an ammonium or iminium cation, as described herein, and the second cation is an ammonium or iminium cation, as described herein. For instance, the first cation A’ may be an ammonium cation as described herein and the second cation A’’ may be an ammonium cation as described herein. Typically the first cation A’ and the second cation A’’ are cations of the formula [R 1 R 2 R 3 R 4 N] + , wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen, unsubstituted or substituted C 1-20 alkyl, and unsubstituted or substituted C 6-12 aryl. For instance, the first cation A’ and the second cation A’’ may be cations of the formula [R 1 R 2 R 3 R 4 N] + , wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen and unsubstituted or substituted C 1 - 10 alkyl, preferably wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen and unsubstituted or substituted C 1-6 alkyl. Preferably at least one of R 1 , R 2 , R 3 and R 4 is not hydrogen. Typically, the first cation A’ is an ammonium or iminium cation having a lower molecular weight than that of the second cation A’’. Alternatively the first cation A’ may be an inorganic cation. For instance, the first cation A’ may be selected from Cs+, methylammonium and formamidinium and the second cation A’’ may be any second cation as described herein. Preferably, the first cation A’ may be methyl ammonium or formamidinium, and the second cation A’’ may be a C 2-18 alkyl ammonium cation, preferably wherein the second cation A’’ is selected from ethyl ammonium, propyl ammonium, butyl ammonium, pentyl ammonium, hexyl ammonium and octyl ammonium. Preferably, the first cation A’ is methyl ammonium and the second cation A’’ is butylammonium. M cations The one or more M cations may be selected from metal monocations, metal dications, metal trications or metal tetracations. Typically, the one or more M cations are selected from metal dications. The one or more M cations may be selected from alkaline earth metal cations, lanthanide cations, transition metal cations and p-block metal cations. Typically, the one or more M cations are comprise one or more of Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ . Preferably the one or more M cations comprise one or more of Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ . Preferably the one or more M cations comprise Pb 2+ . The first precursor compound comprising the one or more M cations cation is typically a salt of the one or more M cations. Typically, the second precursor compound comprises the one or more M cations and one or more counter-anions. Many such counter-anions are known to the skilled person. The counter-anion may be a halide anion, a thiocyanate anion (SCN ), a tetrafluoroborate anion (BF 4 -) or an organic anion. Preferably, the counter-anion as described herein is a halide anion or an organic anion. The film-forming solution may comprise two or more counter-anions, e.g. two or more halide anions. Typically, the counter-anion is an anion of formula RCOO , ROCOO , RSO 3 , ROP(O)(OH)O or RO , wherein R is H, substituted or unsubstituted C 1-10 alkyl, substituted or unsubstituted C2-10 alkenyl, substituted or unsubstituted C 2-10 alkynyl, substituted or unsubstituted C 3-10 cycloalkyl, substituted or unsubstituted C 3-10 heterocyclyl or substituted or unsubstituted aryl. For instance R may be H, substituted or unsubstituted C 1-10 alkyl, substituted or unsubstituted C 3-10 cycloalkyl or substituted or unsubstituted aryl. Typically R is H substituted or unsubstituted C 1-6 alkyl or substituted or unsubstituted aryl. For instance, R may be H, unsubstituted C 1-6 alkyl or unsubstituted aryl. Thus, R may be selected from H, methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopentyl, cyclohexyl and phenyl. Often, (one or more) counter-anions are selected from halide anions (e.g. F , Cl , Br and I ) and anions of formula RCOO , wherein R is H or methyl. Typically, the counter-anion is F , Cl , Br , I , formate or acetate. Preferably, the counter-anion is Cl , Br , I or F . More preferably, the counter- anion is Cl , Br or I . Typically, the first precursor compound is a compound of formula MY, MY 2 , MY 3 , or MY 4 , wherein M is an M cation as described herein, and Y is said counter-anion. Thus, the first precursor compound may be a compound of formula MY or MY 2 , wherein M is an M cation as described herein, preferably wherein M is selected from Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ , and Y is F–, Cl–, Br–, I–, formate or acetate. Preferably M is an cation selected from Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ and Y is Cl , Br , I , formate or acetate, preferably Cl , Br or I . When two or more M cations are present, two or more first precursor compounds, as described herein may be present in the precursor composition. Typically, the first precursor compound is soluble in the solvent. Thus, the first precursor compound may be present in the precursor composition dissolved in the solvent. Both the first precursor compound and the second precursor compound may be soluble in the compound. Thus the precursor composition may be a solution comprising (a) the one or more M cations, which one or more M cations are metal or metalloid cations, and optionally one or more counter-anions; (b) the first cation A’, and optionally one or more counter-anions; and (c) a solvent, wherein the solvent comprises: (i) a compound which provides the second cation A’’ as described herein; and (ii) an organic solvent. Thus the process may comprise dissolving one or more first precursor compounds, as described herein, in the solvent to form the precursor composition. X anions [X] comprises one or more halide anions. For instance [X] may comprise two or more halide anions or three or more halide anions. The one or more halide anions are typically selected from the group consisting of F-, Cl-, Br- and I-. Optionally the one or more halide anions are selected from the group consisting of Cl-, Br- and I-. Preferably the one or more halide anions comprise I- or Br-. For instance, the one or more halide anions may comprise I- and Br-. Preferably the one or more halide anions comprise I-. The one or more halide anions may be I- and Br- (i.e. [X] consists of I- and Br-). Preferably [X] is I- The one or more halide anions may be present as counter-anions to the one or more M cations and/or the first cation A’. Thus, the first and/or second precursor compounds may comprise one or more halide anions, of which [X] comprises in the crystalline compound produced. Overall structure The compound comprises layers and/or chains of corner-sharing MX 6 octahedra separated by the second cation A’’. This structure is useful because an existing corner-sharing MX 6 lattice is necessary to closely mimic the eventual cubic 3D perovskite and minimise lattice-rearrangement upon conversion. The compound may comprise 1-dimensional chains of corner-sharing [MX 6 ] octahedra separated by the second cation A’’. In such structures, preferably the first cation A’ and the second cation A’’ are both organic cations, as described herein. Typically, the one or more cations, M, are dications. Thus, the compound may comprise -dimensional chains of corner-sharing [MX 6 ] 4- octahedra separated by the second cation A’’. The compound may comprise an extended network of corner-sharing [MX 6 ] octahedra consisting of 2D planes of [A’] a [M] b [X] c separated by the second cation A’’. In such structures, preferably the first cation A’ and the second cation A’’ are both organic cations, as described herein. Typically, the one or more cations, M, are dications. Thus, the compound may comprise an extended network of corner-sharing [MX 6 ] octahedra consisting of 2D planes of [A’] a [M] b [X] c separated by the second cation A’’. Examples of such structures are Ruddlesden-Popper phases and Dion-Jacobsen phases. Typically, the crystalline compound of formula [A] a [M] b [X] c is a Ruddlesden-Popper phase. Thus, typically the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I): A’ n-1 A’’ 2 [M] n [X] 3n+1 wherein A’ is as described herein, A’’ is as described herein, [M] is as described herein and [X] is as described herein, and wherein n is a number from 1 to 3, typically where x is a number from 1 to 2.5. Preferably, the crystalline compound of formula [A] a [M] b [X] c does not feature a significant fraction of Ruddlesden-Popper phases with n > 3, as complete conversion of such phases to 3D structures, such as 3D perovskite structures, is challenging. For instance, n maybe a number from 1.5 to 2. n may be a number from 1.1 to 1.9. Preferably n is a number from 1.3 to 2. For instance, may be a number which is about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about 1.7, about 1.8 or about 1.9. Preferably, n is about 1.7. The value n may be related to the value [R] by the formula <n> = 2[R] -1 +1. [R] is defined as the ratio [A’’]:[A’] in the first crystalline A/M/X material i.e. [R] =[A’’]:[A’]. The inventors have surprisingly found that when [R] and n are within certain ranges of values, as described herein, the crystalline compound produced is particularly well-suited to conversion to a three-dimensional perovskite, [A][M][X] 3 , which has improved thermal stability compared to perovskite materials prepared by conventional routes, without compromising on the optoelectronic properties. Typically, the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the first cation A’ and the second cation A’’ are both organic cations. For instance, the crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ and the second cation A’’ are both organic cations, preferably in which the first cation A’ is an ammonium or iminium cation, as described herein, and the second cation A’’ is an ammonium or iminium cation, as described herein. For instance, the crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ may be an ammonium cation as described herein and the second cation A’’ may be an ammonium cation as described herein. Typically, the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more M cations comprise one or more cations selected from the group consisting of Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ . Preferably the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more M cations comprise one or more cations selected from the group consisting of Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ . Preferably the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more M cations comprise Pb 2+ . Typically, the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more halide anions are selected from the group consisting of F-, Cl-, Br- and I-. Optionally the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more halide anions are selected from the group consisting of Cl-, Br- and I-. Preferably the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more halide anions comprise I- or Br-. For instance, the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more halide anions comprise I- and Br-. Preferably the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more halide anions comprise I-. Typically, the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the first cation A’ and the second cation A’’ are both organic cations, the one or more M cations comprise one or more cations selected from the group consisting of Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ and the one or more halide anions are selected from the group consisting of F-, Cl-, Br- and I-. For instance, the crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ is an ammonium or iminium cation, as described herein, and the second cation A’’ is an ammonium or iminium cation, as described herein, M cations comprise one or more cations selected from the group consisting of Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ and the one or more halide anions are selected from the group consisting of F-, Cl-, Br- and I-. For instance, the crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ is an ammonium cation as described herein and the second cation A’’ is an ammonium cation as described herein, the one or more M cations are selected from the group consisting of Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ and the one or more halide anions are selected from the group consisting of Cl-, Br- and I-. Preferably, the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the first cation A’ and the second cation A’’ are cations of the formula [R 1 R 2 R 3 R 4 N] + , wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen and unsubstituted or substituted C 1 - 10 alkyl, preferably wherein the first cation has a lower molecular weight than the second cation, the one or more M cations are selected from the group consisting of Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ and the one or more halide anions are selected from the group consisting of Cl-, Br- and I-. For instance, the crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ is methyl ammonium and the second cation A’’ is selected a C 2-10 alkyl ammonium cation, preferably wherein the second cation A’’ is selected from ethyl ammonium, propyl ammonium, butyl ammonium, pentyl ammonium and hexyl ammonium, preferably, the first cation A’ is methyl ammonium and the second cation A’’ is butylammonium; the one or more M cations are selected from the group consisting of Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ and the one or more halide anions X are selected from the group consisting of Cl-, Br- and I-. The crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ is methyl ammonium, the second cation A’’ is butyl ammonium, the one or more M cations comprise Pb 2+ and the one or more halide anions X comprise Br- and/or I-. Thus, the compound of Formula I may be a compound of formula IA: [CH 3 NH 3 ] n-1 [CH 3 CH 2 CH 2 NH 3 ] 2 [Pb] n [I] 3n+1 wherein n is a number from 1 to 2.5. For instance, n maybe a number from 1.5 to 2. n may be a number from 1.1 to 1.9. Preferably n is a number from 1.3 to 2. For instance, may be a number which is about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about 1.7, about 1.8 or about 1.9. Preferably, n is about 1.7. The crystalline compound of formula [A] a [M] b [X] c may be a Dion-Jacobson phase. Thus, typically the crystalline compound of formula [A] a [M] b [X] c is a is a compound of formula (II) A’ n-1 A’’M n X 3n+1 wherein the first cation A’ is as described herein, the second cation A’’ is as described herein, [M] is as described herein and [X] is as described herein, and wherein n is from 1 to 3. In compound of formula (II), preferably the second cation A’’ is an organic cation. Typically, the second cation A’’ is an organic monocation or an organic dication. The second cation A’’ typically has a radius larger than the first cation A’. Thus, the second A cation A’’ may be an organic cation with a charge of 2+ and radius larger than the first A cation, A’ or the second A cation, A’’ may be an organic cation with a charge of 1+ and radius larger than A’. For instance, the second A cation, A’’ cation may be an alkyldiammonium cation as described herein, typically octylenediammonium. The second A cation, A’’ may be dication which is an (alkylammonium)pyridinium, typically an m- (alkylammonium)pyridinium where m is from 2 to 4 and the alkyl group is C 1-20 alkyl. The crystalline compound of formula [A] a [M] b [X] c may comprise alternating first A’ and second A’’ cations in the interlayer space. Other process steps Typically, the precursor composition is disposed on the substrate by solution phase deposition. For instance, the process may comprise disposing the precursor composition on the substrate by gravure coating, slot dye coating, screen printing, ink jet printing, doctor blade coating, spray coating, roll- to-roll (R2R) processing, spin-coating, chemical bath coating and dip-coating. Preferably, the precursor composition is a solution, and the process comprises disposing the precursor composition on the substrate by gravure coating, slot dye coating, screen printing, ink jet printing, doctor blade coating, spray coating, roll-to-roll (R2R) processing, spin-coating, chemical bath coating and dip- coating. Typically, the process further comprises removing the solvent to form the layer comprising the first A/M/X material. Removing the solvent may comprise heating the solvent, or allowing the solvent to evaporate. The solvent is usually removed by heating the precursor composition treated substrate. For instance, the process may further comprise heating the substrate with the precursor composition disposed thereon. Preferably wherein the substrate is heated to a temperature of from 50°C to 350°C. More preferably the substrate is heated to a temperature of from 50°C to 200°C for a time of from 1 to 100 minutes. 2D intermediate material The invention also provides a first crystalline A/M/X material obtainable by the process as described herein. Optionally the first crystalline A/M/X material is in the form of a layer comprising the material. The invention also provides a first crystalline A/M/X material comprising a crystalline compound of formula (I): A’ n-1 A’’ 2 [M] n [X] 3n+1 wherein the first cation A’ is as described herein, the second cation A’’ is as described herein, [M] is as described herein and [X] is as described herein, and wherein n is a number from 1.1 to 1.9. For instance, n may be a number about 1.1, about 1.2, about 1.3, about 1.4, about 1.5, about 1.6, about 1.7, about 1.8 or about 1.9. Preferably n is about 1.7. Typically, the first crystalline A/M/X material is in the form of a layer comprising the material. Typically, the layer has a thickness of from 10 nm to 100 µm, for instance from 50 nm to 10 µm, from 100 nm to 2000 nm, preferably from 300 nm to 1000 nm. Typically, the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the first cation A’ and the second cation A’’ are both organic cations as described herein. For instance, the crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ and the second cation A’’ are both organic cations, preferably in which the first cation A’ is an ammonium or iminium cation, as described herein, and the second cation A’’ is an ammonium or iminium cation, as described herein. For instance, the crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ may be an ammonium cation as described herein and the second cation A’’ may be an ammonium cation as described herein. Typically, the crystalline compound of formula [A]a[M]b[X]c is a compound of formula (I) in which the one or more M cations are selected from the group consisting of Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ . Preferably the crystalline compound of formula [A]a[M]b[X]c is a compound of formula (I) in which the one or more M cations are selected from the group consisting of Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ . Preferably the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more M cations comprise Pb 2+ . Typically, the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more halide anions are selected from the group consisting of F-, Cl-, Br- and I-. Optionally the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more halide anions are selected from the group consisting of Cl-, Br- and I-. Preferably the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more halide anions comprise I- or Br-. For instance, the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more halide anions comprise I- and Br-. Preferably the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the one or more halide anions comprise I-. Typically, the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) in which the first cation A’ and the second cation A’’ are both organic cations, the one or more M cations are selected from Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ and the one or more halide anions are selected from the group consisting of F-, Cl-, Br- and I-. For instance, the crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ is an ammonium or iminium cation, as described herein, and the second cation A’’ is an ammonium or iminium cation, as described herein, M cations are selected from the group consisting of Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ and the one or more halide anions are selected from the group consisting of F-, Cl-, Br- and I-. For instance, the crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ is an ammonium cation as described herein and the second cation A’’ is an ammonium cation as described herein, the one or more M cations are selected from Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ and the one or more halide anions are selected from the group consisting of Cl-, Br- and I-. Preferably, the crystalline compound of formula [A]a[M]b[X]c is a compound of formula (I) in which the first cation A’ and the second cation A’’ are cations of the formula [R 1 R 2 R 3 R 4 N] + , wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen and unsubstituted or substituted C 1 - 10 alkyl, preferably wherein the first cation has a lower molecular weight than the second cation, the one or more M cations are selected from Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ and the one or more halide anions are selected from the group consisting of Cl-, Br- and I-. For instance, the crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ is methyl ammonium and the second cation A’’ is selected a C 2-10 alkyl ammonium cation, preferably wherein the second cation A’’ is selected from ethyl ammonium, propyl ammonium, butyl ammonium, pentyl ammonium and hexyl ammonium, preferably, the first cation A’ is methyl ammonium and the second cation A’’ is butylammonium; the one or more M cations are selected from Pb 2+ , Ge 2+ , Sn 2+ , Ag + , Bi 3+ ,Sb 3+ , Cu 2+ , In 1+ , In 3+ , Pd 2+ , Pb 4+ , Cu + , Sn 4+ , and Ti 4+ and the one or more halide anions X are selected from the group consisting of Cl-, Br- and I-. The crystalline compound of formula [A] a [M] b [X] c may be a compound of formula (I) in which the first cation A’ is methyl ammonium, the second cation A’’ is butyl ammonium, the one or more M cations comprise Pb 2+ and the one or more halide anions X comprise Br- and/or I-. Preferably, A’ is methylammonium, A’’ is butylammonium, [M] is Pb and [X] is I- or Br-. Conversion process The invention also provides a process for producing a layer comprising a second crystalline A/M/X material, which process comprises: exposing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c , and wherein the layer comprising the first crystalline A/M/X material is disposed on a substrate, to one or more conversion cations, A c , wherein: [M] comprises one or more M cations, which one or more first cations are metal or metalloid cations; [A] comprises one or more A cations, wherein the one or more second cations comprise a first cation A’ and a second cation A’’, wherein the second cation A’’ is different from the first cation; [X] comprises one or more halide anions; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19 wherein the compound comprises layers and/or chains of corner-sharing MX 6 octahedra separated by the second cation A’’. The first crystalline A/M/X material may be any first crystalline material as described herein. The one or more M cations may be any M cations as described herein. The first cation A’ may be any first cation A’ as described herein. The second cation A’’ may be any second cation A’’ as described herein. Conversion cations The one or more conversion cations, A c , may replace the first cation, A’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. The one or more conversion cations, A c , may replace all of the first cation, A’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. The one or more conversion cations, A c , may replace a portion of the first cation, A’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. The one or more conversion cations, A c , may replace the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. The one or more conversion cations, A c , may replace all of the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. The one or more conversion cations, A c , may replace a portion of the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. The one or more conversion cations, A c , may replace the first cation, A’, and the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. The one or more conversion cations, A c , may replace all of the first cation, A’, and all of the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. The one or more conversion cations, A c , may replace a portion of the first cation, A’, and a portion of the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. Typically, the one or more conversion cations, A c , are different from the first cation, A’, and the second cation, A’’. The one or more conversion cations, A c , may be the same as the first cation, A’. The one or more conversion cations, A c , may be the same as the second cation, A’’. The one or more conversion cations, A c , may be selected from the group consisting of inorganic cations and organic cations. Typically, the one or more conversion cations, A c , are selected from the group consisting of alkali metal cations and organic cations as described herein, for instance, from the group consisting of alkali metal cations, ammonium cations, diammonium cations and iminium cations. For instance, the one or more conversion cations, A c , may be selected from the group consisting of Cs + , Rb + , K + and Na + . The one or more conversion cations, A c , may be selected from the group consisting of ammonium cations, as described herein, or iminium cations as described herein. For instance, the one or more conversion cations, A c , may be selected from ammonium cations of formula [R 1 R 2 R 3 R 4 N] + , wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen, unsubstituted or substituted C 1-20 alkyl, and unsubstituted or substituted C 6-12 aryl. The one or more conversion cations, A c , may be selected from ammonium cations of formula [R 1 R 2 R 3 R 4 N] + , wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen and unsubstituted or substituted C 1 - 10 alkyl, preferably wherein each of R 1 , R 2 , R 3 , R 4 is independently selected from hydrogen and unsubstituted or substituted C 1-6 alkyl. Preferably at least one of R 1 , R 2 , R 3 and R 4 is not hydrogen. The one or more conversion cations, A c , may be selected from organic dications. For instance, one or more conversion cations, A c , may be selected from diammonium cations. Typically, diammonium cations are of formula [H 3 N(CH 2 ) n NH 3 ] 2+ , in which n is from 1 to 20, preferably in which n is from 1 to 10, for example where n is from 1 to 6. The one or more conversion cations, A c , may be selected from the group consisting of methylenediammonium [(NH 3 CH 2 NH 3 ) 2+ ], ethylenediammonium [(NH 3 CH 2 CH 2 NH 3 ) 2+ ], propylenediammonium [(NH 3 CH 2 CH 2 CH 2 NH 3 ) 2+ ], butylenediammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 NH 3 ) 2+ ], pentylenediammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ], hexylenediammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ], heptylenediammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ] and octylenediammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ]. Preferably one or more conversion cations, A c , comprise or are methylenediammonium [(NH 3 CH 2 NH 3 ) 2+ ]. The one or more conversion cations, A c , may selected from dialkyl ammonium cations, i.e. a cation of general formula [R 1 R 2 R 3 R 4 N] + , wherein two of R 1 to R 4 are alkyl and the other two are hydrogen. For instance, the one or more conversion cations, A c , may be selected from cations of general formula [R 1 R 2 R 3 R 4 N] + , wherein R 1 and R 2 are each independently selected from unsubstituted or substituted C 1-20 alkyl, preferably wherein R 1 and R 2 are each independently selected from unsubstituted or substituted C 1 - 10 alkyl, and wherein R 3 and R 4 are hydrogen. For instance, the one or more conversion cations, A c , may comprise dimethylammonium [(CH 3 ) 2 NH 2 + ]. The one or more conversion cations, A c , may be selected from iminium cations of formula [R 5 R 6 N=CH-NR 7 R 8 ] + , wherein each of R 5 , R 6 , R 7 and R 8 is independently selected from hydrogen, unsubstituted or substituted C 1 - 20 alkyl, and unsubstituted or substituted C 6-12 aryl. The one or more conversion cations, A c , may be selected from iminium cations of general formula [R 5 R 6 N=CH- NR 7 R 8 ] + , wherein each of R 5 , R 6 , R 7 and R 8 is independently selected from hydrogen and unsubstituted or substituted C 1 - 10 alkyl, preferably wherein each of R 5 , R 6 , R 7 and R 8 is independently selected from hydrogen and unsubstituted or substituted C 1 - 6 alkyl. Preferably, the one or more conversion cations, A c , may be selected from formamidinium cations and guanidinium cations. Preferably, the one or more conversion cations, A c , are selected from the group consisting of Cs + , Rb + , K + , Na + , methylammonium [(CH 3 NH 3 ) + ], formamidinium [(H 2 N-C(H)=NH 2 ) + ], dimethylammonium [(CH 3 ) 2 NH 2 + ], methylenediammonium [(NH 3 CH 2 NH 3 ) 2+ ], ammonium (NH 4 + ) and guanidinium [(H 2 N-C(NH 2 )=NH 2 ) + ]. For instance, the one or more conversion cations A c , may be selected from methylammonium, Cs + and formamidinium [(H 2 N-C(H)=NH 2 ) + ]. More preferably the one or more conversion cations, A c , are selected from Cs + and formamidinium [(H 2 N-C(H)=NH 2 ) + ]. Typically, the conversion cation A c , is formamidinium [(H 2 N-C(H)=NH 2 ) + ]. Typically, exposing the layer comprising a first crystalline A/M/X material to one or more conversion cations, A c , comprises contacting the layer comprising the first crystalline A/M/X material with one or more conversion compounds comprising the one or more conversion cations, A c . The one or more conversion compounds may be a salt or salts of one or more conversion cations, A c , or a compound or compounds which provide the one or more conversion cations, A c , in situ. Preferably, exposing a layer comprising a first crystalline A/M/X material to one or more conversion cations, A c , comprises contacting the layer comprising the first crystalline A/M/X material with a salt or salts of one or more conversion cations, typically where the salt or salts of the one or more conversion cations, A c , is dissolved in a solvent. Thus, typically, exposing a layer comprising a first crystalline A/M/X material to one or more conversion cations, A c , comprises contacting the layer comprising the first crystalline A/M/X material with a solution of a salt or salts of one or more conversion cations, A c . Thus the process may comprise dissolving the salt or salts of one or more conversion cations, A c , in a solvent to form a solution, then contacting the layer comprising the first crystalline A/M/X material with the solution. Typically, the salt or salts of one or more conversion cations, A c comprise the one or more conversion cations, A c , and one or more counter-anions. Many such counter-anions are known to the skilled person. The counter-anion may be a halide anion, a thiocyanate anion (SCN ), a tetrafluoroborate anion (BF 4 ) or an organic anion. Preferably, the counter-anion as described herein is a halide anion or an organic anion. The film-forming solution may comprise two or more counter-anions, e.g. two or more halide anions. The counter-anion may be an anion of formula RCOO , ROCOO , RSO 3 , ROP(O)(OH)O or RO , wherein R is H, substituted or unsubstituted C 1-10 alkyl, substituted or unsubstituted C2-10 alkenyl, substituted or unsubstituted C 2-10 alkynyl, substituted or unsubstituted C 3-10 cycloalkyl, substituted or unsubstituted C 3-10 heterocyclyl or substituted or unsubstituted aryl. For instance R may be H, substituted or unsubstituted C 1-10 alkyl, substituted or unsubstituted C 3-10 cycloalkyl or substituted or unsubstituted aryl. Typically R is H substituted or unsubstituted C1-6 alkyl or substituted or unsubstituted aryl. For instance, R may be H, unsubstituted C 1-6 alkyl or unsubstituted aryl. Thus, R may be selected from H, methyl, ethyl, propyl, butyl, pentyl, hexyl, cyclopentyl, cyclohexyl and phenyl. Often, (one or more) counter-anions are selected from halide anions (e.g. F , Cl , Br and I ) and anions of formula RCOO , wherein R is H or methyl. Typically, the counter-anion is F , Cl , Br , I-, formate or acetate. Preferably, the counter-anion is Cl , Br , I or F . More preferably, the counter- anion is Cl , Br or I . Typically, the salt or salts of one or more conversion cations, A c comprise a compound of formula A c Y or A c Y 2 , wherein A c is a conversion cation as described herein, and Y is said counter-anion. Thus, the salt or salts of one or more conversion cations, A c may comprise a compound of formula A c Y, wherein A c is a conversion cation as described herein, and Y is F , Cl , Br , I , formate or acetate. Preferably A c is an ammonium cation, a diammonium cation or an iminium cation as described herein and Y is Cl , Br , I , formate or acetate, preferably Cl , Br , I . The one or more conversion compounds are typically halide salts of the one or more conversion cations, A c . Thus, preferably the process comprises contacting the layer comprising the first crystalline A/M/X material with a solution of the halide salts of the one or more conversion cations, A c , more preferably wherein the halide salts are iodide or bromide salts. For instance, the salt or salts of one or more conversion cations, A c may comprise a formamidinium salt, typically a formamidinium halide salt. Preferably, the salt or salts of one or more conversion cations, A c comprise formamidinium iodide and/or formamidinium bromide. Solvents/vapour processing The process may comprises contacting the layer comprising the first crystalline A/M/X material with a solution comprising the one or more conversion cations, A c , and a solvent. As explained, the one or more conversion cations, A c , may be present as a salt or salts of the one or more conversion cations, A c , which are dissolved in the solvent to form the solution. Typically, the solvent is a polar solvent. For instance, the solvent may be a solvent with a Gutmann acceptor number of more than 27. Preferably the solvent is an alcohol. Typically, when the solvent is an alcohol and the second cation is an ammonium cation, the alcohol has a substituent group which is the same as a substituent group on the second cation A’’. For instance wherein the alcohol is a C 1-8 alkyl alcohol and the second organic cation A’’ has the same C 1-8 alkyl substituent. Thus, when the second organic cation A’’ is methylammonium, the alcohol may be methanol, when the second organic cation A’’ is ethylammonium, the alcohol may be ethanol, when the second organic cation A’’ is propylammonium, the alcohol may be propanol, when the second organic cation A’’ is butylammonium, the alcohol may be butanol, when the second organic cation A’’ is pentylammonium, the alcohol may be pentanol, and when the second organic cation A’’ is hexylammonium, the alcohol may be hexanol etc. Preferably, the second organic cation A’’ is butylammonium and the solvent is butanol. Typically, the process further comprises heating the substrate. This may be performed to remove any solvent leftover from a solution comprising the one or more conversion cations, A c . Preferably wherein the substrate is heated to a temperature of from 50°C to 350°C. More preferably the substrate is heated to a temperature of from 50°C to 200°C for a time of from 1 to 100 minutes. The process may comprise contacting the layer comprising the first crystalline A/M/X material with a vapour comprising the one or more conversion cations, A c , to form the second crystalline A/M/X material. Typically, the vapor is formed by evaporation one or more conversion compounds, as described herein. For instance, the vapor may be formed by evaporating one or more halide salts of the one or more conversion cations, A c , as described herein. Structure of materials Typically, the structure of the second crystalline A/M/X material is different from the structure of the first crystalline A/M/X material. Typically, where a layered first crystalline A/M/X material is employed, upon conversion an increase in symmetry from an orthorhombic to primitive cubic space group occurs. However, a skilled person would appreciate that the second crystalline A/M/X material might alternatively be indexed with a related lower-symmetry distorted structure, such as orthorhombic, tetragonal or trigonal phases. The first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c comprising layers and/or chains of corner-sharing MX 6 octahedra separated by the second cation A’’. Typically, the first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c comprising 1-dimensional chains of corner-sharing [MX 6 ] octahedra separated by the second cation A’’. In such structures, preferably the first cation A’ and the second cation A’’ are both organic cations, as described herein. Typically, the one or more cations, M, are dications. Thus, the compound may comprise 1-dimensional chains of corner-sharing [MX 6 ] 4- octahedra separated by the second cation A’’. The first crystalline A/M/X material may comprise a crystalline compound of formula [A] a [M] b [X] c comprising an extended network of corner-sharing [MX 6 ] octahedra consisting of 2D planes of [A’] a [M] b [X] c separated by the second cation A’’. In such structures, preferably the first cation A’ and the second cation A’’ are both organic cations, as described herein. Typically, the one or more cations, M, are dications. Thus, the crystalline compound of formula [A] a [M] b [X] c may comprise an extended network of corner-sharing [MX 6 ] 4- octahedra consisting of 2D planes of [A’] a [M] b [X] c separated by the second cation A’’. Examples of such structures are Ruddlesden-Popper phases and Dion-Jacobsen phases. Typically, the crystalline compound of formula [A] a [M] b [X] c in the first A/M/X material is a Ruddlesden-Popper phase, as described herein. The crystalline compound of formula [A] a [M] b [X] c n the first A/M/X material may be a Dion-Jacobson phase, as described herein. Typically, the second crystalline A/M/X material comprises a crystalline compound having a three- dimensional crystal structure. Preferably, the second crystalline A/M/X material comprises a crystalline compound having a three-dimensional perovskite crystal structure. For instance, the second crystalline A/M/X material comprises a crystalline compound having a three-dimensional cubic perovskite crystal structure. Such three-dimensional structures are related to that of CaTiO 3 , and comprise a network of corner-sharing [MX 6 ] octahedral extending in three dimensions, rather than separated layers or chains or corner-sharing [MX 6 ] octahedra. The second crystalline A/M/X material may comprise a compound of formula (III) [A][M][X] 3 wherein [A] comprises the one or more conversion cations, A c , as described herein, [M] comprises one or more M cations, which one or more first cations are metal or metalloid cations as described herein, and [X] comprises one or more halide anions, as described herein. [A] may comprise or consist of the one or more conversion cations, A c , as described herein. When [A] comprises the one or more conversion cations, A c , [A] may also comprise a first cation, A’, as described herein and/or a second cation A’’, as described herein. For instance, [A] may comprise the one or more conversion cations, A c , as described herein and the first cation, A’, as described herein. [A] may comprise the one or more conversion cations, A c , as described herein and the second cation, A’’, as described herein. [A] may comprise the one or more conversion cations, A c , as described herein and the first cation, A’, as described herein and the second cation, A’’, as described herein. Thus, [A] may comprise one or more conversion cations, A c , selected from the group consisting of Cs + , Rb + , K + , Na + , methylammonium [(CH 3 NH 3 ) + ], formamidinium [(H 2 N-C(H)=NH 2 ) + ], dimethylammonium [(CH3)2NH2 + ], methylenediammonium [(NH3CH2NH3) 2+ ], ammonium (NH4 + ) and guanidinium [(H 2 N-C(NH 2 )=NH 2 ) + ]. For instance, [A] may comprise one or more conversion cations A c , selected from the group consisting of methylammonium, Cs + and formamidinium [(H 2 N-C(H)=NH 2 ) + ]. More preferably, [A] may comprise one or more conversion cations, A c , selected from the group consisting of Cs + and formamidinium [(H 2 N-C(H)=NH 2 ) + ]. Typically, [A] comprises a conversion cation A c , which is formamidinium [(H 2 N-C(H)=NH 2 ) + ]. Typically, the crystalline compound of formula (III) is one in which the one or more M cations are selected from the group consisting of Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ . Preferably the crystalline compound of formula (III) is one in which the one or more M cations are selected from the group consisting of Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ . Preferably the crystalline compound of of formula (III) is one in which the one or more M cations comprise Pb 2+ . Typically, the crystalline compound of formula (III) is one in which the one or more halide anions are selected from the group consisting of F-, Cl-, Br- and I-. Optionally the crystalline compound of formula (III) is one in which the one or more halide anions are selected from the group consisting of Cl-, Br- and I-. Preferably the crystalline compound of formula (III) is one in which the one or more halide anions comprise I- or Br-. Preferably, the crystalline compound of formula (III) is one in which the one or more halide anions comprise I- and Br-. For instance, the crystalline compound of formula (III) may be one in which the one or more halide anions comprise I-. Typically, the crystalline compound of formula (III) is one in which [A] comprises one or more conversion cations, A c , selected from the group consisting of alkali metal cations, ammonium cations, diammonium cations and iminium cations, as described herein, the one or more M cations are selected from the group consisting of Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ and the one or more halide anions are selected from the group consisting of F-, Cl-, Br- and I-. For instance, the crystalline compound of formula (III) is one in which [A] comprises one or more conversion cations, A c , selected from the group consisting of ammonium cations, diammonium cations and iminium cations, as described herein, as described herein, the one or more M cations are selected from the group consisting of Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ and the one or more halide anions are selected from the group consisting of F-, Cl-, Br- and I-. For instance, the crystalline compound of formula (III) is one in which [A] comprises one or more conversion cations, A c , selected from the group consisting of Cs + , Rb + , K + , Na + , methylammonium [(CH 3 NH 3 ) + ], formamidinium [(H 2 N-C(H)=NH 2 ) + ], dimethylammonium [(CH 3 ) 2 NH 2 + ], methylenediammonium [(NH 3 CH 2 NH 3 ) 2+ ], ammonium (NH 4 + ) and guanidinium [(H2N-C(NH2)=NH2) + ], the one or more M cations are selected from the group consisting of Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ and the one or more halide anions are selected from the group consisting of Cl-, Br- and I-. Preferably, the crystalline compound of formula (III) is one in which [A] comprises one or more conversion cations, A c , selected from the group consisting of methylammonium, Cs + and formamidinium [(H 2 N-C(H)=NH 2 ) + ], the one or more M cations are selected from Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ and the one or more halide anions are selected from the group consisting of Cl-, Br- and I-. For instance, the compound of formula (III) is one in which [A] comprises one or more conversion cations, A c , selected from the group consisting of Cs + , formamidinium [(H 2 N-C(H)=NH 2 ) + ] and methylammonium; the one or more M cations are selected from Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ and the one or more halide anions X are selected from the group consisting of Cl-, Br- and I-. The compound of formula (III) may be one in which [A] comprises one or more conversion cations, A c , selected from the group consisting of Cs + , formamidinium [(H 2 N-C(H)=NH 2 ) + ] and methylammonium, the one or more M cations comprise Pb 2+ and the one or more halide anions X comprise Br- and/or I-. Preferably, [A] comprises conversion cations, A c , comprising formamidinium [(H 2 N-C(H)=NH 2 ) + ] and methylammonium, [M] comprises Pb 2+ and [X] comprises I- or Br-. Thus, the second crystalline A/M/X material may be a compound having formula (H 2 N- C(H)=NH 2 ) y (CH 3 NH 3 ) 1-y Pb(I x Br 1-x ) 3 , wherein x and y are values from 0 to 1. The second crystalline A/M/X material may be compound having the formula (H 2 N-C(H)=NH 2 ) y Cs 1-y Pb(I x Br 1-x ) 3 wherein x and y are values from 0 to 1. Entire process Typically, the process for producing a layer comprising a second crystalline A/M/X material further comprises producing the layer comprising the first crystalline A/M/X material by a process as described herein. For instance, the process may comprise: • producing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c , wherein: [M] comprises one or more M cations, which one or more M cations are metal or metalloid cations, as described herein; [A] comprises one or more A cations, wherein the one or more A cations comprise a first cation A’ and a second cation A’’, as described herein, wherein the second cation A’’ is different from the first cation A’; [X] comprises one or more halide anions, as described herein; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19; and wherein the compound comprises layers and/or chains of corner-sharing MX 6 octahedra separated by the second cation A’’; wherein the process comprises disposing on a substrate a precursor composition comprising: (a) a first precursor compound comprising the one or more M cations, which one or more M cations are metal or metalloid cations; (b) a second precursor compound comprising the first cation A’; and (c) a solvent, wherein the solvent comprises: (i) a compound which provides the second cation A’’; and (ii) an organic solvent, as described herein; and: • exposing the layer comprising the first crystalline A/M/X material to one or more conversion cations, A c , as described herein, to form a layer comprising a second crystalline A/M/X material. Thus, the first crystalline A/M/X material may be used as a template material for the second crystalline A/M/X material. The first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c comprising layers and/or chains of corner-sharing MX 6 octahedra separated by the second cation A’’, as described herein. Typically, the second crystalline A/M/X material comprises a crystalline compound having a three-dimensional crystal structure. Thus, the process typically comprises converting the first crystalline A/M/X material, comprising a crystalline compound of formula [A] a [M] b [X] c to a higher dimensionality second crystalline A/M/X material. The step of producing a layer comprising a first crystalline A/M/X material may be performed using any of the process conditions and A/M/X ions as described herein for producing the first crystalline A/M/X material. The step of exposing the layer comprising the first crystalline A/M/X material to one or more conversion cations, A c , as described herein, to form a layer comprising a second crystalline A/M/X material, may be performed using any of the process conditions or combination of A/M/X ions as described herein. Substrate In any process of the invention, the substrate is typically a component for a semiconductor device. For instance, the substrate may comprise a first or second electrode, as described herein, and disposed on that electrode, an n-type layer or a p-type layer, as described herein. The substrate may comprise a further photoactive region, as described herein. In that case, the semiconductor device may be a tandem or multi-junction semiconductor device, for instance a tandem or multi-junction photovoltaic device. Thus the invention also provides a process for producing a semiconductor device comprising producing a film comprising a crystalline compound on a substrate using a process as described herein, and disposing one or more further components on the film to produce a semiconductor device. Typically, the film has a thickness of from 10 nm to 100 µm, for instance from 50 nm to 10 µm, from 100 nm to 2000 nm, preferably from 300 nm to 1000 nm. For instance, the process may further comprise disposing one or more n-type or a p-type layers, as described herein, on the film of the crystalline compound, then disposing a first or second electrode, as described herein, on the n-type or p-type layer. The skilled person would be well aware of methods for disposing such layers, for instance by spin-coating. The invention also provides a process for producing a semiconductor device, which process comprises producing a layer comprising a second crystalline A/M/X material on a substrate, by a process as described herein, and disposing one or more further components on the layer comprising the second crystalline A/M/X material to produce a semiconductor device. For instance, the process may further comprise disposing one or more n-type or a p-type layers, as described herein, on the film of the crystalline compound, then disposing a first or second electrode, as described herein, on the n-type or p-type layer. The skilled person would be well aware of methods for disposing such layers, for instance by spin-coating. Product film The invention also provides a layer comprising a second crystalline A/M/X material obtainable by the process as described herein. Typically, the layer has a thickness of from 10 nm to 100 µm, for instance from 50 nm to 10 µm, from 100 nm to 2000 nm, preferably from 300 nm to 1000 nm. The invention also provides a layer comprising crystalline (H 2 N-C(H)=NH 2 )PbI 3 wherein the (H 2 N- C(H)=NH 2 )PbI 3 exhibits an increase of less than 1.5% per hour in the ratio of the PbI 2 (001) reflection to the perovskite (100) reflection when measured using X-ray diffraction analysis at a temperature of 130 ºC. The PbI 2 (001) reflection is typically observed at about 2θ = 12.7º and corresponds to the reflection from the (001) set of planes in the hexagonal PbI 2 lattice. The skilled person would be well aware of methods for measuring such reflections, for instance, both reflections may be measured and monitored using X-ray diffraction on a temperature controlled stage. For instance, the measurements may be made using a rigaku smartlab diffractometer equipped with a copper K-α X-ray source (λ = 0.15406 nm). The perovskite (100): PbI 2 (001) ratio may be calculated via integration of each respective reflection. The invention also provides a layer comprising crystalline (H 2 N-C(H)=NH 2 )PbI 3 wherein the (H 2 N- C(H)=NH 2 )PbI 3 exhibits a residual solvent content of no more than 0.01 % by mass. For instance, the measurements may be made using a thermal desorption-gas chromatography-mass spectrometry facility and using an absolute standard of the appropriate solvent to determine the total mass of evolved residual solvent. Device The invention also provides a semiconductor device obtainable by a process as described herein. The invention also provides a semiconductor device comprising a layer as described herein. The semiconductor device may be an optoelectronic device (for instance a photovoltaic device, a solar cell, a photodetector, a photomultiplier, a photoresistor, a charge injection laser, a photodiode, a photosensor, a chromogenic device, a light-sensitive transistor, a phototransistor, a light-emitting device, an electroluminescent device, or a light-emitting diode, an X-ray scintillator), a luminescent device (for instance a phosphor in a display or in lighting), a transistor, a solid state triode, a battery, a battery electrode, a radiation detector, a capacitor or a super-capacitor. Typically, the semiconductor device is an optoelectronic device. For instance, the semiconductor device may be selected from a photovoltaic device, a photodiode, a solar cell, a photodetector, a phototransistor, a photomultiplier, a photoresistor, a chromogenic device, a light-sensitive transistor, a light emitting device, a light emitting diode, a charge injection laser, a photodetector or an X-ray scintillator. The semiconductor device may be a photovoltaic device. For instance, the semiconductor device may be selected from a single-junction photovoltaic device, a tandem junction photovoltaic device or a multi-junction photovoltaic device, for instance from a single-junction solar cell, a tandem junction solar cell or a multi-junction solar cell. The semiconductor device may be a light emitting device. For instance, the semiconductor device may be a light emitting diode, a display screen or a solid-state lighting device. The second crystalline A/M/X material may be in any form within the semiconducting device. Typically the second crystalline A/M/X material is in the form of a layer, for instance a photoactive, photoemissive or photoabsorbent, layer. Typically, the layer has a thickness of from 10 nm to 100 µm, for instance from 50 nm to 10 µm, from 100 nm to 2000 nm, preferably from 300 nm to 1000 nm. Preferably, the second crystalline A/M/X material is present in the form of a film as described herein. Thus, the semiconductor device may comprise a layer of the second crystalline A/M/X material having a thickness of 2 µm or less. The second crystalline A/M/X material often acts as a photoactive component (e.g. a photoabsorbent component or a photoemissive component) within the semiconductor device. The second crystalline A/M/X material may alternatively act as a p-type semiconductor component, an n-type semiconductor component, or an intrinsic semiconductor component in the semiconductor device. For instance, the second crystalline A/M/X material may form a layer of a p-type, n-type or intrinsic semiconductor in a transistor, e.g. a field effect transistor. For instance, the second crystalline A/M/X material may form a layer of a p-type or n-type semiconductor in an optoelectronic device, e.g. a solar cell or an LED. Typically, the semiconductor device comprises: an n-type region comprising at least one n-type layer; a p-type region comprising at least one p-type layer; and, disposed between the n-type region and the p-type region: a layer comprising the second crystalline A/M/X material. For instance, the semiconductor device is often an optoelectronic device, which optoelectronic device comprises: an n-type region comprising at least one n-type layer; a p-type region comprising at least one p-type layer; and, disposed between the n-type region and the p-type region: a layer of semiconducting material which comprises (or consists essentially of) said second crystalline A/M/X material, as defined herein. The optoelectronic device may be a tandem device. The tandem optoelectronic device may comprise an n-type region comprising at least one n-type layer; a p-type region comprising at least one p-type layer; and, disposed between the n-type region and the p-type region: a layer of semiconducting material which comprises (or consists essentially of) said second crystalline A/M/X material, as defined herein, a charge recombination layer, and a layer of a second semiconductor. An n-type layer is typically a layer of an n-type semiconductor. A p-type layer is typically a layer of a p-type semiconductor. The n-type region comprises at least one n-type layer. The n-type region may comprise an n-type layer and an n-type exciton blocking layer. Such an n-type exciton blocking layer is typically disposed between the n-type layer and the layer(s) comprising the semiconducting material. The n- type region may have a thickness of from 1 nm to 1000 nm. For instance, the n-type region may have a thickness of from 5 nm to 100 nm, or from 10 nm to 50 nm. Preferably, the n-type region comprises a compact layer of an n-type semiconductor. The n-type semiconductor may be selected from a metal oxide, a metal sulphide, a metal selenide, a metal telluride, a perovskite, amorphous Si, an n-type group IV semiconductor, an n-type group III- V semiconductor, an n-type group II-VI semiconductor, an n-type group I-VII semiconductor, an n- type group IV-VI semiconductor, an n-type group V-VI semiconductor, and an n-type group II-V semiconductor, any of which may be doped or undoped. Typically, the n-type semiconductor is selected from a metal oxide, a metal sulphide, a metal selenide, and a metal telluride. For instance, the n-type region may comprise an inorganic material selected from oxide of titanium, tin, zinc, niobium, tantalum, tungsten, indium, gallium, neodymium, palladium, or cadmium, or an oxide of a mixture of two or more of said metals. For instance, the n-type layer may comprise TiO 2 , SnO 2 , ZnO, SnO, Nb 2 O 5 , Ta 2 O 5 , WO 3 , W 2 O 5 , In 2 O 3 , Ga 2 O 3 , Nd 2 O 3 , PbO, or CdO. The n-type region may comprise an organic electron transporting materials, for instance C 60 , Phenyl-C61-butyric acid methyl ester (PCBM), Bis-PCBM, or 3,9-bis(2-methylene-(3-(1,1-dicyanomethylene)-indanone))- 5,5,11,11-tetrakis(4-hexylphenyl)-dithieno[2,3-d:2’,3’-d ’]-s-indaceno[1,2-b:5,6-b’]dithiophene. The n-type region may comprise an inorganic/organic bilayer such as a TiO 2 / fullerene bilayer, SnO/fullerene bilayer or a ZnO/ fullerene bilayer. Typically, the n-type region comprises SnO 2 or TiO 2 , for instance a compact layer of TiO 2 or SnO 2 or nanoparticles of TiO 2 or SnO 2 . Often, the n-type region also comprises a layer of a fullerene or a fullerene derivative (for instance C60 or Phenyl-C61-butyric acid methyl ester (PCBM)). Typically, the n-type region comprises TiO 2 , SnO 2 , ZnO, SnO, C 60 , PCBM, Bis-PCBM, 3,9-bis(2- methylene-(3-(1,1-dicyanomethylene)-indanone))-5,5,11,11-tet rakis(4-hexylphenyl)-dithieno[2,3- d:2’,3’-d’]-s-indaceno[1,2-b:5,6-b’]dithiophene, or an inorganic/organic bilayer such as a TiO 2 / fullerene bilayer, SnO/fullerene bilayer or a ZnO/fullerene bilayer. Preferably, the p-type region comprises a compact layer of a p-type semiconductor. Suitable p-type semiconductors may be selected from polymeric or molecular hole transporters. The p-type layer employed in the semiconductor device of the invention may for instance comprise spiro- OMeTAD (2,2’,7,7’-tetrakis-(N,N-di-p-methoxyphenylamine)9,9’- spirobifluorene)), P3HT (poly(3- hexylthiophene)), PCPDTBT (Poly[2,1,3-benzothiadiazole-4,7-diyl[4,4-bis(2-ethylhexyl)- 4H- cyclopenta[2,1-b:3,4-b’]dithiophene-2,6-diyl]]), PVK (poly(N-vinylcarbazole)), HTM-TFSI (1- hexyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide), Li-TFSI (lithium bis(trifluoromethanesulfonyl)imide), tetracene, MeO-TPD (N,N,N′,N′-Tetrakis(4- methoxyphenyl)benzidine), poly-TPD (Poly[N,N’-bis(4-butylphenyl)-N,N’-bisphenylbenzidine]), PTAA (Poly[bis(4-phenyl)(2,4,6-trimethylphenyl)amine]), [4-(3,6-Dimethyl-9H-carbazol-9- yl)butyl]phosphonic Acid (Me-4PACz), [4-(3,6-Dimethoxy-9H-carbazol-9-yl)butyl]phosphonic acid (MeO-4PACz), [2-(3,6-Dimethyl-9H-carbazol-9-yl)ethyl]phosphonic acid (Me-2PACz) or tBP (tert-butylpyridine). The p-type region may comprise carbon nanotubes. Usually, the p-type material is selected from spiro-OMeTAD, P3HT, PTAA, PCPDTBT and PVK. Preferably, the p-type layer employed in the optoelectronic device comprises spiro-OMeTAD. In some embodiments, the p-type layer may comprise an inorganic hole transporter. For instance, the p-type layer may comprise an inorganic hole transporter comprising an oxide of nickel, vanadium, copper or molybdenum; Ga 2 O 3 , CuSCN, NiO, CuI, CuBr, CuSCN, Cu 2 O, CuO or CIS; a perovskite; amorphous Si; a p-type group IV semiconductor, a p-type group III-V semiconductor, a p-type group II-VI semiconductor, a p-type group I-VII semiconductor, a p-type group IV-VI semiconductor, a p-type group V-VI semiconductor, and a p-type group II-V semiconductor, which inorganic material may be doped or undoped. The p-type layer may be a compact layer of said inorganic hole transporter. Typically, the p-type layer comprises a p-type material selected from NiO, Ga 2 O 3 , CuSCN, CuI, and CuO, spiro-OMeTAD, MeO-TPD, Tetracene, P3HT, Poly-TPD, Me-4PACz, MeO-4PACz, Me- 2PACz or PTAA. The semiconductor device typically further comprises one or more first electrodes and one or more second electrodes. The one or more first electrodes are typically in contact with the n-type region, if such a region is present. The one or more second electrodes are typically in contact with the p-type region, if such a region is present. Typically: the one or more first electrodes are in contact with the n-type region and the one or more second electrodes are in contact with the p-type region; or the one or more first electrodes are in contact with the p-type region and the one or more second electrodes are in contact with the n-type region. The first and second electrode may comprise any suitable electrically conductive material. The first electrode typically comprises a transparent conducting oxide. The second electrode typically comprises one or more metals. The second electrode may alternatively comprise graphite, graphite oxide or graphite-graphite oxide blends. Typically, the first electrode comprises a transparent conducting oxide and the second electrode comprises one or more metals. The transparent conducting oxide typically comprises fluorine-doped tin oxide (FTO), indium tin oxide (ITO) or aluminium-doped zinc oxide (AZO), and typically FTO or ITO. The second electrode typically comprises a metal selected from silver, gold, copper, aluminium, platinum, palladium, or tungsten. Each electrode may form a single layer or may be patterned. The semiconductor device (for instance an optoelectronic device such as a photovoltaic device, or a light emitting device) may comprise the following layers in the following order: I. one or more first electrodes as defined herein; II. an n-type region comprising at least one n-type layer as defined herein; III. a layer of the semiconducting material comprising the second crystalline A/M/X material as defined herein; IV. a p-type region comprising at least one p-type layer as defined herein; and V. one or more second electrodes as defined herein. The semiconductor device (for instance a photovoltaic device, or a light emitting device) may comprise the following layers in the following order: I. one or more first electrodes which comprise a transparent conducting oxide, preferably FTO; II. an n-type region comprising at least one n-type layer as defined herein; III. a layer of the semiconducting material comprising the second crystalline A/M/X material as defined herein; IV. a p-type region comprising at least one p-type layer as defined herein; and V. one or more second electrodes which comprise a metal, preferably silver or gold. The one or more first electrodes may have a thickness of from 100 nm to 700 nm, for instance of from 100 nm to 400 nm. The one or more second electrodes may have a thickness of from 10 nm to 500 nm, for instance from 50 nm to 200 nm or from 10 nm to 50 nm. The n-type region may have a thickness of from 1 nm to 500 nm. The p-type region may have a thickness of from 1 nm to 500 nm. The semiconductor device (for instance a photovoltaic device) of the invention may be a single- junction device. Alternatively, it may be a tandem junction or multi-junction device, for instance a tandem junction or multi-junction solar cell. In a tandem junction or multi-junction devices (for instance tandem junction or multi-junction photovoltaic devices) of the invention, the herein disclosed crystalline compounds may be combined with known technologies to deliver optimised performance. Typically, when the photovoltaic device of the invention is a tandem junction photovoltaic device, the device additionally comprises a further photoactive region, i.e. a further region which absorbs light and which may then generate free charge carriers. The further photoactive region is other than the region which comprises the layer comprising the second crystalline A/M/X material and the adjacent layers comprising charge-transporting materials (electron- and hole- transporting materials, respectively). The further photoactive region is generally outside of the region which comprises the layer comprising the second crystalline A/M/X material and the adjacent layers comprising charge (electron- and hole-) transporting materials. Thus, the further photoactive region may be disposed between the first electrode and the layer comprising a charge (electron or hole) transporting material, or between the second electrode and the layer comprising a charge (hole or electron) transporting material, in the device of the invention as defined herein. Typically, when the photovoltaic device of the invention is a multi-junction photovoltaic device, the device additionally comprises a plurality of further photoactive regions. Each one of the further photoactive regions may be disposed between the first electrode and the layer comprising a charge (electron or hole) transporting material, or between the second electrode and the layer comprising a charge (hole or electron) transporting material, in the device of the invention as defined herein. Typically, the or each further photoactive region comprises at least one layer of a semiconductor material. The semiconductor material may for instance comprise silicon. It may for instance comprise crystalline silicon. Alternatively, for example, the semiconductor material may comprise copper zinc tin sulphide, copper zinc tin selenide, copper zinc tin selenide sulphide, copper indium gallium selenide, copper indium gallium diselenide or copper indium selenide. Thus, for instance, when the photovoltaic device of the invention is a tandem junction photovoltaic device, the further photoactive region may be a conventional silicon solar cell. The further photoactive region may be a conventional thin film solar cell which may, for instance, comprise crystalline silicon (c-Si) or another thin film technology such as copper zinc tin sulphide, copper zinc tin selenide, copper zinc tin selenide sulphide, copper indium gallium selenide, copper indium gallium diselenide or copper indium selenide. The further photoactive region is preferably a silicon sub-cell. When the photovoltaic device of the invention is a multi-junction photovoltaic device, at least one of the further photoactive regions may be a conventional silicon solar cell. At least one of the further photoactive regions may be a conventional thin film solar cell which may, for instance, comprise crystalline silicon or another thin film technology such as copper zinc tin sulphide, copper zinc tin selenide, copper zinc tin selenide sulphide, copper indium gallium selenide, copper indium gallium diselenide or copper indium selenide. Preferably, at least one of the further photoactive regions is a silicon sub-cell, typically a silicon sub-cell comprising crystalline silicon. Thus, the photovoltaic device may be a multi-junction photovoltaic device comprising silicon sub-cell comprising crystalline silicon. In one preferred embodiment, however, the optoelectronic device of the present invention is a light- emitting device. It may for instance be a light emitting diode. The invention also provides the use of a second crystalline A/M/X material as described herein as a luminescent material, preferably as a phosphor. Examples t 2D-3D α-FAPbI 3 via binary 2-methyltetrahydrofuran:n-butylamine solvent system Materials Fluorine-doped tin oxide-coated glass substrates (15 Ω cm -2 , AMG), tin (IV) oxide (15 wt. % in H 2 O colloidal dispersion, Alfa Aesar), lead(II) iodide (99.99 %, trace metal basis, Tokyo Chemical Industries), methylammonium iodide (>99.99 %, Greatcell Solar Materials), formamidinium iodide (>99.99 %, Greatcell Solar Materials), phenethylammonium iodide (>99 %, Greatcell Solar Materials), spiro-OMeTAD (2,2',7,7'-Tetrakis(N,N-di-p-methoxyphenylamino)-9,9'-spirob ifluoren, >99.5 %, Luminescence Technology Corp.), FK209 Co(III) TFSI salt (tris(2-(1H-pyrazol-1-yl)-4- tert-butylpyridine)cobalt(III) tri[bis(trifluoromethane)sulfonimide], 98 %, Sigma Aldrich), bis(trifluoromethylsulfonyl)amine lithium salt (99.95 %, Sigma Aldrich), gold pellets (99.999 %, Kurt J. Lesker Company). n-butylamine (99.5 %, Sigma Aldrich), 2-methyltetrahydrofuran (Biorenewable, anhydrous, >99.0 %, contains 250 ppm BHT as inhibitor, Sigma Aldrich), tetrahydrofuran (anhydrous, >99.9 %, contains 250 ppm BHT as inhibitor, Sigma Aldrich), n-butanol (anhydrous, 99.8 %, Sigma Aldrich), 2-propanol (anhydrous, 99.5 %, Sigma Aldrich), chlorobenzene (anhydrous, 99.8 %, Sigma Aldrich), acetonitrile (anhydrous, 99.8 %, Sigma Aldrich), 4-tert-butylpyridine (98 %, Sigma Aldrich). Fabrication A colloidal suspension of tin oxide nanoparticles (400 μL) was diluted with ultrapure water (2,600 μL). In an atmosphere containing minimum moisture (<5 % relative humidity), 200 μL of this solution was placed statically on a UV-ozone treated (15 minutes) substrate coated with a fluorine- doped tin oxide layer (15 Ω cm -2 ), then spun at 4,000 rpm (1,000 rpm s -1 ) for 30 seconds before being immediately annealed at 150 °C for 30 minutes in the same environment. The substrates were allowed to cool, then immediately subjected to a further 15 minutes of UV-ozone treatment before being immediately used in the following processing step. 2-methyltetrahydrofuran (1,500 μL) and n-butylamine (1.899 mmol, 187.6 μL) were added to lead iodide (1.266 mmol, 583.5 mg) and methylammonium iodide (1.139 mmol, 181.1 mg) and agitated until all solids were fully dissolved.50 μL of this solution was spin-coated dynamically on top of the SnO 2 layer at 2,500 rpm for 45 seconds in an environment at between 20-22 % relative humidity and <22 °C. The substrates were immediately annealed at 70 °C for 10 minutes in the same environment. After cooling, the substrates were coated with 350 μL of a 0.1 M solution of formamidinium iodide (0.500 mmol, 86.0 mg) dissolved in n-butanol (5,000 μL). After 45 seconds of static soaking, the substrates were spun at 4,000 rpm (1,000 rpm s -1 ) for 45 seconds, then immediately annealed for 10 minutes at 70 °C, followed by 30 minutes at 180 °C. The substrates were allowed to cool, then a 20 mM solution of phenethylammonium iodide (0.200 mmol, 49.8 mg) in 2-propanol (10,000 μL) was spin-coated dynamically on top at 5,000 rpm for 45 seconds, in a N 2 -containing glovebox. A solution of spiro-OMeTAD (0.070 mmol, 85.8 mg) dissolved in chlorobenzene (1,000 μL) and doped with 8.4 μL of a 0.250 M solution of tris(2-(1H-pyrazol-1-yl)-4-tert-butylpyridine)cobalt(III) tri[bis(trifluoromethane)sulfonimide] in acetonitrile, 19.4 μL of a 1.800 M solution of bis(trifluoromethylsulfonyl)amine lithium salt in acetonitrile, and tert-butyl pyridine (0.231 mmol, 38.0 μL). This solution was spin-coated on the PEAI-passivated substrates dynamically at 2,500 rpm for 30 seconds, in a N 2 -containing glovebox. Finally, 75 nm of gold was evaporated on top of the substrates at an initial rate of 0.1 As -1 at a pressure < 2 x 10 -6 torr. Characterisation Steady-State Photoluminescence PL measurements were acquired using a time-correlated single photon counting (TCSPC) setup (FluoTime 300, PicoQuant GmbH). Samples were photoexcited using a 507 nm laser (LDH-P-C- 510, Pico Quant GmbH) pulsed at a frequency of 40 MHz. The PL was collected using a high- resolution monochromator and hybrid photomultiplier detector assembly (PMA Hybrid 40, PicoQuant GmbH). Photoluminescence measurements are shown in Figures 2 and 6. Figure 2 demonstrates the range of mixed-phase 2D perovskite compositions (first crystalline A/M/X material) accessible via the ether-amine solvent system described herein. Figure 6 shows how conversion from 2D template to 3D perovskite (second crystalline A/M/X material) occurs via transformation through a series of hybrid butylammonium-, methylammonium- and formamidinium- based 2D phases. Importantly, the consistent red-shift in luminescence throughout conversion suggests that the haloplumbate inorganic lattice already present in the 2D template is retained during conversion. Ultraviolet-Visible Absorption Spectroscopy Reflectance and transmittance spectra were recorded on a Varian Cary 1050 UV Vis spectrophotometer equipped with an integrating sphere. From these measurements, in combination with the photoactive layer thickness, absorption coefficients were calculated assuming a direct bandgap semi-conductor. Results are shown in Figures 5, 12, 13, 16, 17, 18. Figure 12A shows the extraction of the optical bandgap of the photoactive (triiodide) material by Tauc Analysis. This is consistent with other state-of-the-art α-FAPbI 3 compositions. Figure 12B extracts the Urbach energy from the same data; the low value presented implies a low sub-bandgap defect density and thus improved optoelectronic properties. Figure 13(A-C) demonstrates the enhanced thermal stability of t 2D-3D FAPbI 3 (second crystalline A/M/X material) compared to other state-of-the-art FA-rich perovskite compositions. Figure 16A shows the effect on absorbance of mixing bromide and iodide in the 2D template (first crystalline A/M/X material). Changes both in phase composition (value of n) and in bandgap are observed. Figure 17A shows the range of optical bandgaps achievable via the t 2D-3D approach by halide alloying. Figure 18B shows the optical bandgap of a particularly promising material with an optical bandgap ideally suited for use in a perovskite/perovskite/silicon triple junction photovoltaic cell. X-ray Diffraction The 1D-XRD spectra were obtained with a Panalytical X’Pert Pro X-Ray diffractometer and 2D- XRD spectra using a Rigaku SmartLab X-ray diffractometer and a HyPix-30002D hybrid pixel array detector, both with CuK α1 (1.54060 Å) source. A heating stage was employed in conjunction with the Rigaku SmartLab diffractometer for relevant measurements. X-ray diffraction spectra are shown in Figures 3, 7, 9, 13, 14, 16 and 17. Figure 3 demonstrates the range of mixed-phase 2D perovskite (first crystalline A/M/X material) compositions accessible via the ether-amine solvent system. Figure 7 reveals that, even after solution conversion, traces quantities of 2D perovskite crystalline domains remain in the second crystalline A/M/X material. These are fully removed by thermal curing. Figure 9 confirms that the use of high-<n> 2D phase mixtures in the first crystalline A/M/X material leads to incomplete conversion and significant PbI 2 domains in the deposited 3D material (second crystalline A/M/X material). Figure 13J highlights the greatly improved thermal stability (130 °C) of t 2D-3D FAPbI 3 (second crystalline A/M/X material) compared to other state-of-the-art FA-rich perovskite compositions. Figure 14 demonstrates an improvement in ambient stability against the same compositions. Scanning Electron Microscopy A FEI Quanta 600 FEG Environmental Scanning Electron Microscope (ESEM) was employed to investigate perovskite layer morphology. Accelerating voltages between 4-15 kV were employed for various analyses. Scanning electron microscopy images are shown in Figures 8 and 18. Figure 8 convincingly demonstrates the importance of fine-control of the <n> of the 2D template (first crystalline A/M/X material) in order to achieve continuous 3D perovskite (second crystalline A/M/X material) layers with optimised PbI 2 content. Nuclear Magnetic Resonance Spectroscopy A two-channel Bruker Avance III HD Nanobay 400 MHz instrument running TOPSPIN 3 equipped with a 5 mm z-gradient broadband/fluorine observation probe is used. The signal from residual non- deuterated DMSO solvent are used for reference. NMR spectra are shown in figures 4 and 11. Thermal Desorption-Gas Chromatography-Mass Spectrometry (TD-GC-MS) Thin layers (<1 μm) of perovskite material on fluorine-doped tin oxide-coated glass substrates were loaded into a thermal extractor unit (Micro-Chamber/Thermal Extractor M-CTE250, Markes International) and heated at 165 °C for 60 minutes under a flow of N 2 gas (50 mL min -1 ). Volatile components released during extraction were collected onto sorbent-packed collection tubes. The sorbent tubes are then loaded into a thermal desorption unit and heated rapidly to desorb the volatiles concentrated in the tube, which are then passed via N 2 carrier gas into the gas chromatography-mass spectrometry instrument (Agilent 5977B GC/MSD). Identification of the volatile components was done by comparison to the NIST 17 Mass Spectral Library. All reported species showed a >95 % match with the database compound. TD-GC-MS results are shown in Figure 15. Figure 15 reveals three key sources of improved stability of t 2D-3D FAPbI 3 (second crystalline A/M/X material): (1) The retention of trace quantities (non-crystalline, see Figure 7, and below the detection limit of 1 H solution NMR estimated to be better than 0.5 mol %) of butylammonium. Such species have been reported previously to passivate grain boundaries and improve ambient perovskite stability (see Wang et al “Efficient ambient-air-stable solar cells with 2D-3D heterostructured butylammonium- caesium-formamidinium lead halide perovskites”, Nature Energy, 2, 17135, 2017). (2) The absence of trace residual solvents. Note: the observation of species with the m/z of butylamine is interpreted as reflecting entrapped butylammonium in the t 2D-3D FAPbI 3 material on account of the low boiling point (78 °C) of butylamine and the harsh thermal treatment of these materials during initial fabrication (180 °C for 30 minutes). (3) The common thermal degradation product of FA-rich perovskites (at >95 °C), sym-triazine (see Ma et al “Temperature-Dependent Thermal Decomposition Pathway of Organic-Inorganic Halide Perovskite Materials”, Chem. Mater, 2019, 31, 20, 85-15- 8522), is not observed as a degradation product of t 2D-3D FAPbI 3 , unlike all other FA-rich perovskites measured. Sym-triazine is formed via the interaction of three formamidinium cations in the solid material, which are first deprotonated (expected to lead to simultaneous HI volatilisation) and then cyclise producing ammonia as a by-product. This degradation route results in remnant PbI 2 contaminant in the second crystalline A/M/X material, as observed in Figure 13 for other state-of- the-art FA-rich perovskites. Characterisation of Solar Cells Current-voltage (J–V) and maximum power point (MPP) measurements were measured (2400 series source meter, Keithley Instruments) under both light (simulated AM 1.5 irradiance generated by a Wavelabs SINUS-220 simulator) and dark. The active area of the solar cell was masked with a metal aperture to either 0.25 or 1.00 cm 2 . The forward J–V scans were measured from forward bias to short- circuit and the backward scans were from short-circuit to forward bias, both at a scan rate of 245 mV s −1 . Active MPP tracking measurements were performed for at least 30 s to obtain stabilised power conversion efficiency. We measured the cells multiple times until a peak performance was achieved. This typically took two to five J–V scan plus MPP tracking iterations, in a measurement time of around 2–5 minutes. J-V spectra are shown in Figure 19. J-V spectra of a further solar cell of the invention, in a “p-i-n” configuration is shown in Figure 22. External Quantum Efficiency External quantum efficiency was acquired with a custom build Fourier transform photocurrent spectrometer utilizing a Bruker Vertex 80v Fourier Transform Interferometer. A Newport AAA sun simulator was used as the light source and the light intensity was calibrated with a Newport-calibrated reference silicon photodiode. Device active areas were masked with a metal aperture, having an active area of 0.25 cm 2 . EQE measurements are shown in Figure 12. Preference for organic channels to facilitate complete transformation into product material. A MAPbI 3 layer (500 nm, processed via acetonitrile/methylamine gas) served as the n = ∞ member of the BA 2 MA n-1 Pb n I 3n+1 family of templates. Conversion to α-FAPbI 3 was attempted by curing at 180 °C for 30 minutes. As shown in Figure 20 (demonstrated by the band-gap edge of the template) complete conversion to lower-bandgap FAPbI 3 was not achieved. For working examples of the invention, the appearance of an absorption feature corresponding to PbI 2 indicates incomplete conversion has been achieved. These findings demonstrate the critical role of controlling the 2D template. While there are other possible ‘template structures’ that possess the same haloplumbate scaffold as FAPbI 3 (for example, MAPbI 3 , as used here) such templates will not have the ideal combination of organic channels (provided by the 2D perovskite material) and haloplumbate scaffold. Material stability under accelerated aging As shown in Figure 21, FAPbI 3 perovskites processed via the material of the invention shows substantially improved stability under extremely harsh aging condition compared to other state-of- the-art perovskites. In particular, stability is demonstrated under high humidity, at high temperature, and under illumination. Stability of p-i-n solar cells The solar cells of the invention were tested for long-term shelf stability. Unencapsulated solar cells were stored in the dark, in dry air at <10 % relative humidity, at room temperature (Figure 23(a)) and stored at high humidity, high temperature and under illumination (Figure 23(b)). As shown in Figure 23, the champion of the invention showed great stability. Performance of FAPbI x Br 3-x Figure 24 shows champion performance of 1.95 eV perovskite material (FAPbI x Br 3-x ), designed for use as the top cell in a silicon-perovskite-perovskite triple junction perovskite solar cell. Figure 24 (a) shows champion JV curves, Figure 24 (b) shows champion stabilised power conversion efficiency, and Figure 24 (c) shows champion stabilised Voc. Further aspects of the invention are set out in the following numbered clauses: 1. A process for producing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c , wherein: [M] comprises one or more M cations, which one or more M cations are metal or metalloid cations; [A] comprises one or more A cations, wherein the one or more A cations comprise a first cation A’ and a second cation A’’, wherein the second cation A’’ is different from the first cation A’; [X] comprises one or more halide anions; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19; and wherein the compound comprises layers and/or chains of corner- sharing MX 6 octahedra separated by the second cation A’’; wherein the process comprises disposing on a substrate a precursor composition comprising: (a) a first precursor compound comprising the one or more M cations, which one or more M cations are metal or metalloid cations; (b) a second precursor compound comprising the first cation A’and (c) a solvent, wherein the solvent comprises: (i) a compound which provides the second cation A’’; and (ii) an organic solvent. 2. The process according to clause 1, wherein the ratio R of the concentration in the precursor composition of the compound which, when protonated, provides the second cation, A’’, to the concentration in the precursor composition of the first organic cation A’, is from 0.75 to 3, preferably wherein R is from 1 to 1.75. 3. The process according to clause 1 or clause 2, wherein the organic solvent comprises an ether, preferably wherein the organic solvent comprises a cyclic ether. 4. The process according to any preceding clause, wherein the second cation A’’ has a larger radius than the first cation A’. 5. The process according to any preceding clause, wherein first cation A’ is an inorganic cation, preferably wherein the first cation A’ is selected from the group consisting of Na + , K + , Cs + , Rb + . 6. The process according to any one of clauses 1 to 4, wherein the first cation A’ is an organic cation, preferably wherein the first cation A’ is selected from the group consisting of ammonium cations and iminium cations, more preferably wherein A’ is selected from ammonium cations, formamidinium cations and guanidinium cations. 7. The process according to any one of clauses 1 to 4 and 6, wherein the first cation A’ is an ammonium cation and wherein the second cation A’’ is an ammonium cation. 8. The process according to any one of the preceding clauses, wherein the first cation A’ has a different molecular weight from the second cation A’’, preferably wherein the first cation A’ is an ammonium cation having a lower molecular weight than that of the second cation A’’. 9. The process according to any one clauses 1 to 4 and 6 to 8, wherein the first cation A’ and the second cation A’’ are cations of the formula [R1R2R3R4N] + , wherein each of R1, R2, R3, R4 is independently selected from hydrogen, unsubstituted or substituted C 1-20 alkyl, and unsubstituted or substituted C 6-12 aryl, preferably wherein at least one of R 1 , R 2 , R 3 and R 4 is not hydrogen. 10. The process according to any one of the preceding clauses, wherein the first cation A’ is methyl ammonium. 11. The process according to any one of the preceding clauses wherein the second cation A’’ is an organic cation, wherein the solvent comprises an organic compound which, when protonated, provides the second organic cation A’’, preferably wherein the second cation A’’ is an ammonium cation, wherein the solvent comprises an amine which, when protonated, provides the second organic cation A’’. 12. The process according to any one of the preceding clauses, wherein the second cation A’’ is selected from the group consisting of propylammonium [(CH 3 CH 2 CH 2 NH 3 ) + ], butylammonium [(CH 3 CH 2 CH 2 CH 2 NH 3 ) + ], pentylammonium [(CH 3 CH 2 CH 2 CH 2 CH 2 NH 3 ) + ], hexylammonium [(CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) + ], heptylammonium [(CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) + ] and octylammonium [(CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) + ], preferably wherein the second cation A’’ is butylammonium [(CH 3 CH 2 CH 2 CH 2 NH 3 ) + ]. 13. The process according to any one of clauses 1 to 11, wherein the second cation A’’ is a dication selected from the group consisting of propyldiammonium [(NH 3 CH 2 CH 2 CH 2 NH 3 ) 2+ ], butyldiammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 NH 3 ) 2+ ], pentyldiammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ], hexyldiammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ], heptyldiammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ] and octyldiammonium [(NH 3 CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ], preferably wherein the second cation A’’ is octyldiammonium [(NH 3 CH 2 CH 2 CH 2 CH 2 NH 3 ) 2+ ]. 14. The process according to any one of clauses 1 to 4 and 5 to 13, wherein the first cation A’ is methyl ammonium and the second cation A’’ is butylammonium. 15. The process according to any one of the preceding clauses, wherein the one or more M cations are selected from Ca 2+ , Sr 2+ , Cd 2+ , Cu 2+ , Ni 2+ , Mn 2+ , Fe 2+ , Co 2+ , Pd 2+ , Ge 2+ , Sn 2+ , Pb 2+ , Yb 2+ , Eu 2+ , Bi 3+ , Sb 3+ , Pd 4+ , W 4+ , Re 4+ , Os 4+ , Ir 4+ , Pt 4+ , Sn 4+ , Ag + , Bi 3+ , Pb 4+ , Ge 4+ and Te 4+ , preferably wherein the one or more M cations are selected from Pb 2+ , Ge 2+ , Sn 2+ , Ag + and Bi 3+ , more preferably wherein the one or more M cations comprise Pb 2+ . 16. The process according to any one of the preceding clauses, wherein the one or more halide anions are selected from F-, Cl-, Br- and I-, optionally wherein the one or more halide anions are selected from Cl-, Br- and I-, preferably wherein the one or more halide anions comprise I- or Br-, more preferably wherein the one or more halide anions comprise I-. 17. The process according to any one of the preceding clauses, wherein the compound comprises an extended network of corner-sharing [MX 6 ] octahedra consisting of 2D planes of [A’] a [M] b [X] c separated by the second cation A’’. 18. The process according to any one of clauses 1 to 16, wherein the compound comprises 1- dimensional chains of corner-sharing sharing [MX 6 ] octahedra separated by the second organic cation A’’. 19. The process according to any one of clauses 1 to 17, wherein the crystalline compound of formula [A] a [M] b [X] c is a Ruddlesden Popper phase. 20. The process according to any one of clauses 1 to 17 and 19, wherein the crystalline compound of formula [A] a [M] b [X] c is a compound of formula (I) A’ n-1 A’’ 2 [M] n [X] 3n+1 wherein A’ is as defined in any one of clauses 1, 4 to 10 and 14, A’’ is as defined in any one of clauses 1, 4 and 7 to 14, [M] is as defined in any one of clauses 1 and 15 and [X] is as defined in any one of clauses 1 and 16, and wherein n is a number from 1 to 2.5, preferably wherein n is a number from 1.3 to 2 or wherein n is a number from 1.1 to 1.9. 21. The process according to any one clauses 1 to 17, wherein the crystalline compound of formula [A] a [M] b [X] c is a Dion-Jacobson phase. 22. The process according to any one of clauses 1 to 17 and 21, wherein the crystalline compound of formula [A] a [M] b [X] c is a is a compound of formula (II) A’ n-1 A’’M n X 3n+1 wherein A’ is as defined in any one of clauses 1, 4 to 10 and 14, A’’ is as defined in any one of clauses 1, 4 and 7 to 14, [M] is as defined in any one of clauses 1 and 15 and [X] is as defined in any one of clauses 1 and 16, and wherein n is from 1 to 3, preferably wherein A’’ is an organic cation with a charge of 2+ and radius larger than A’ or wherein A’’ is an organic cation with a charge of 1+ and radius larger than A’. 23. The process according to any one of clauses 1 to 17 and 19 to 22, wherein the crystalline compound of formula [A] a [M] b [X] c comprises alternating A’ and A’’ cations in the interlayer space. 24. The process according to any one of clauses 3 to 23, wherein the cyclic ether is tetrahydrofuran, 2-methyltetrahydrafuran or a mixture thereof. 25. The process according to any one of the preceding clauses, wherein the process comprises disposing the precursor composition on the substrate by gravure coating, slot dye coating, screen printing, ink jet printing, doctor blade coating, spray coating, roll-to-roll (R2R) processing, spin- coating, chemical bath coating and dip-coating. 26. The process according to any one of the preceding clauses, wherein the process further comprises removing the solvent to form the layer comprising the first A/M/X material. 27. A process according to any one of the preceding clauses, wherein the process further comprises heating the substrate with the precursor composition disposed thereon, preferably wherein the substrate is heated to a temperature of from 50°C to 350°C, more preferably wherein the substrate is heated to a temperature of from 50°C to 200°C for a time of from 1 to 100 minutes. 28. A first crystalline A/M/X material obtainable by the process as defined in any one of clauses 1 to 27, optionally wherein the first crystalline A/M/X material is in the form of a layer comprising the material. 29. A first crystalline A/M/X material comprising a crystalline compound of formula (I): A’ n-1 A’’ 2 [M] n [X] 3n+1 wherein A’ is as defined in any one of clauses 1, 4 to 10 and 14, A’’ is as defined in any one of clauses 1, 4 and 7 to 14, [M] is as defined in any one of clauses 1 and 15 and [X] is as defined in any one of clauses 1 and 16, and wherein n is a number from 1.1 to 1.9, optionally wherein the first crystalline A/M/X material is in the form of a layer comprising the material. 30. A first crystalline A/M/X material according to clause 29 wherein A’ is methylammonium, A’’ is butylammonium, [M] is Pb and [X] is I. 31. A process for producing a layer comprising a second crystalline A/M/X material, which process comprises: exposing a layer comprising a first crystalline A/M/X material, which first crystalline A/M/X material comprises a crystalline compound of formula [A] a [M] b [X] c , and wherein the layer comprising the first crystalline A/M/X material is disposed on a substrate, to one or more conversion cations, A c , wherein: [M] comprises one or more M cations, which one or more first cations are metal or metalloid cations; [A] comprises one or more A cations, wherein the one or more second cations comprise a first cation A’ and a second cation A’’, wherein the second cation A’’ is different from the first cation; [X] comprises one or more halide anions; a is a number from 1 to 7; b is a number from 1 to 6; and c is a number from 1 to 19 wherein the compound comprises layers and/or chains of corner-sharing MX 6 octahedra separated by the second cation A’’. 32. The process according to clause 31, wherein the one or more conversion cations, A c , replace the first cation, A’, and/or the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. 33. The process according to clause 32, wherein the one or more conversion cations, A c , replace all of the first cation, A’, and/or all of the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. 34. The process according to clause 32, wherein the one or more conversion cations, A c , replace a portion of the first cation, A’, and/or a portion of the second cation, A’’, in the first crystalline A/M/X material to form the second crystalline A/M/X material. 35. The process according to any one of clauses 31 to 34, wherein the first crystalline A/M/X material is as defined in any one of clauses 1 and 17 to 23. 36. The process according to any one of clauses 31 to 35, wherein the one or more conversion cations, A c , are different from the first cation, A’, and the second cation, A’’. 37. The process according to any one of clauses 31 to 36, wherein the one or more conversion cations, A c , are selected from the group consisting of alkali metal cations and organic cations, preferably wherein the one or more conversion cations, A c , are selected from the group consisting of Cs + , Rb + , K + , Na + , methylammonium [(CH3NH3) + ], formamidinium [(H2N-C(H)=NH2) + ], dimethylammonium [(CH 3 ) 2 NH 2 + ], methylenediammonium [(NH 3 CH 2 NH 3 ) 2+ ], ammonium (NH 4 + ) and guanidinium [(H 2 N-C(NH 2 )=NH 2 ) + ], more preferably wherein the one or more conversion cations A c , are selected from methylammonium, Cs + and formamidinium [(H 2 N-C(H)=NH 2 ) + ]. more preferably still wherein the one or more conversion cations, A c , are selected from Cs + and formamidinium [(H 2 N-C(H)=NH 2 ) + ]. even more preferably wherein the conversion cation A c , is formamidinium [(H 2 N-C(H)=NH 2 ) + ]. 38. The process according to any one of clauses 31 to 37, wherein the first cation A’ is as defined in any one of clauses 1, 4 to 10 and 14. 39. The process according to any one of clauses 31 to 38, wherein the second cation A’’ is as defined in any one of clauses 1, 4 and 7 to 14. 40. The process according to any one of clauses 31 to 39, wherein the one or more M cations are as defined in any one of clauses 1 and 15. 41. The process according to any one of clauses 31 to 40, wherein the one or more halide anions, X are as defined in any one of clauses 1 and 16. 42. The process according to any one of clauses 31 to 41, wherein the structure of the second crystalline A/M/X material is different from the structure of the first crystalline A/M/X material. 43. The process according to any one of clauses 31 to 42, wherein the second crystalline A/M/X material comprises a crystalline compound having a three dimensional crystal structure. 44. The process according to any one of clauses 31 to 43, wherein the second crystalline A/M/X material comprises a compound of formula (III) [A][M][X] 3 wherein [A] comprises the one or more conversion cations, A c , as defined in any one of clauses 31, 36 and 37, [M] is as defined in any one of clauses 1 and 15, and [X] is as defined in any one of clauses 1 and 16. 45. The process according to any one of clauses 31 to 44, wherein the second crystalline A/M/X material is (H 2 N-C(H)=NH 2 ) y (CH 3 NH 3 ) 1-y Pb(I x Br 1-x ) 3 wherein x and y are values from 0 to 1. 46. The process according to any one of clauses 31 to 45, wherein the process comprises contacting the layer comprising the first crystalline A/M/X material with one or more conversion compounds comprising the one or more conversion cations, A c . 47. The process according to clause 46, wherein the one or more conversion compounds are halide salts of the one or more conversion cations, A c ; preferably wherein the process comprises contacting the layer comprising the first crystalline A/M/X material with a solution of the halide salts of the one or more conversion cations, A c ; more preferably wherein the halide salts are iodide or bromide salts. 48. The process according to any one of clauses 31 to 47, wherein the process comprises contacting the layer comprising the first crystalline A/M/X material with a solution comprising the one or more conversion cations, A c , and a solvent, preferably wherein the solvent is an alcohol, more preferably wherein the solvent is an alcohol and the second cation is an ammonium cation, wherein the alcohol has a substituent group which is the same as a substituent group on the second cation A’’, for instance wherein the alcohol is a C 1-8 alkyl alcohol and the second organic cation A’’ has the same C 1-8 alkyl substituent, more preferably wherein the second organic cation A’’ is butylammonium and the solvent is butanol. 49. The process according to any one of clauses 31 to 46, wherein process comprises contacting the layer comprising the first crystalline A/M/X material with a vapour comprising the one or more conversion cations, A c , to form the second crystalline A/M/X material. 50. The process according to any one of clauses 31 to 49, further comprising heating the substrate, preferably wherein the substrate is heated to a temperature of from 50°C to 350°C, more preferably wherein the substrate is heated to a temperature of from 50°C to 200°C for a time of from 1 to 100 minutes. 51. The process according to any one of clauses 1 to 27 and 31 to 50, wherein the substrate is a component for a semiconductor device. 52. The process according to any one of clauses 31 to 51, wherein the process further comprises producing the layer comprising the first crystalline A/M/X material by a process as defined in any one of clauses 1 to 27. 53. A layer comprising a second crystalline A/M/X material obtainable by the process of any one of clauses 31 to 51. 54. A layer comprising crystalline (H 2 N-C(H)=NH 2 )PbI 3 wherein the (H 2 N-C(H)=NH 2 )PbI 3 exhibits an increase of less than 1.5% per hour in the ratio of the PbI 2 (001) reflection to the perovskite (100) reflection when measured using X-ray diffraction analysis at a temperature of 130 ºC. 55. A layer comprising crystalline (H 2 N-C(H)=NH 2 )PbI 3 wherein the (H 2 N-C(H)=NH 2 )PbI 3 exhibits a residual solvent content of no more than 0.01 % by mass. 56. A process for producing a semiconductor device, which process comprises producing a layer comprising a second crystalline A/M/X material on a substrate, by a process as defined in any one of clauses 31 to 52, and disposing one or more further components on the layer comprising the second crystalline A/M/X material to produce a semiconductor device. 57. A semiconductor device obtainable by the process of clause 56. 58. A semiconductor device comprising a layer as defined in any one of clauses 53 to 55. 59. A process according to clause 56, or a semiconductor device according to clause 57 or clause 58, wherein the semiconductor device is an optoelectronic device. 60. A process according to clause 56, or a semiconductor device according to clause 57 or clause 58, wherein the semiconductor device is selected from a photovoltaic device, a photodiode, a solar cell, a photodetector, a phototransistor, a photomultiplier, a photoresistor, a chromogenic device, a light-sensitive transistor, a light emitting device, a light emitting diode, a charge injection laser, a photodetector or an X-ray scintillator. 61. A process according to clause 56, or a semiconductor device according to any one of clauses 57 to 60, wherein the semiconductor device is a photovoltaic device, optionally wherein the semiconductor device is selected from a single-junction photovoltaic device, a tandem junction photovoltaic device or a multi-junction photovoltaic device, for instance from a single-junction solar cell, a tandem junction solar cell or a multi-junction solar cell. 62. A process according to clause 56, or a semiconductor device according to any one of clauses 57 to 60, wherein the semiconductor device is a light emitting device, optionally wherein the semiconductor device is a light emitting diode, a display screen or a solid-state lighting device. 63. Use of a second crystalline A/M/X material as defined in any one of clauses 53 to 55 as a phosphor. The project leading to this application has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 76487.